{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Case Study: Prescriptions vs Health Status\n",
    "\n",
    "1.\tDefining a Patient’s Health Status. Ideally, your characterization would be useful for establishing something like “Patient 0123 has anemia and skin infection.”\n",
    "\n",
    "2.\tPredicting Heath Status using Prescription Data alone. \n",
    "\n",
    "## EDA\n",
    "\n",
    "- [Load data sets](#e1)\n",
    "- [Explore data sets](#e2)\n",
    "- [Understand the patient cohort](#e3)\n",
    "- [Diagnosis and prescription dates](#e4)\n",
    "- [Analyze diagnoses in terms of ICD10 codes](#e5)\n",
    "\n",
    "### Defining health status\n",
    "\n",
    "- [From diagnosis codes to defining health status](#q1a)\n",
    "- [Observing patients and diagnoses as temporal sequences](#q1b)\n",
    "- [Sequencing diagnosis data](#q1c)\n",
    "- [Diagnosis sequence, disease progression and health status](#q1d)\n",
    "- [Using primary diagnoses (plural) characterize health status](#q1e)\n",
    "  - Identifying most important diagnoses using TF-IDF measure as an example\n",
    "\n",
    "### Predicting health status using prescriptions\n",
    "\n",
    "- [Analyzing prescription data](#q2a)\n",
    "- [Encoding prescriptions](#q2b)\n",
    "- [Sequencing prescriptios (Optional)](#q2c)\n",
    "- [Identifying important prescriptions (Optional)](#q2d)\n",
    "- [Using (temporally-aligned) prescriptions to predict health status](#q2e)\n",
    "- [Model formulation](#q2f)\n",
    "  - Matching prescriptions with diagnoses via temporal alignment\n",
    "- [Creating training examples](#q2g)\n",
    "- [Model training and evaluation](#q2h)\n",
    "- [Other potential methods](#q2i)\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Import libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The following analysis was performed under:\n",
      "- Python v3.7.1 (default, Dec 14 2018, 13:28:58) \n",
      "[Clang 4.0.1 (tags/RELEASE_401/final)]\n",
      "\n",
      "- Pandas version 1.2.0\n",
      "\n",
      "- Numpy version: 1.19.2\n"
     ]
    }
   ],
   "source": [
    "import sys, os\n",
    "import re  \n",
    "import collections\n",
    "import numpy as np\n",
    "import pandas as pd \n",
    "from pandas import DataFrame, Series\n",
    "import matplotlib.pyplot as plt\n",
    "from matplotlib.ticker import MaxNLocator # used to force yticks to assume integer values\n",
    "plt.style.use('ggplot')\n",
    "\n",
    "# user-defined libraries\n",
    "# import utils\n",
    "from data_pipeline import load_data, fraction_rows_missing\n",
    "import feature_extractor as fext\n",
    "\n",
    "# Import relevant libraries, classes and utilty functions\n",
    "from utils import * # length_of_history, time_window, transform_diagnosis, etc. \n",
    "from utils import Diagnosis, Treatment\n",
    "from icd_utils import encode, decode, is_disease_specific, is_valid_icd\n",
    "\n",
    "# set random state seed for reproducibility \n",
    "np.random.seed(53)\n",
    "\n",
    "print(f\"The following analysis was performed under:\\n- Python v{sys.version}\\n\\n- Pandas version {pd.__version__}\")\n",
    "print(f\"\\n- Numpy version: {np.__version__}\")\n",
    "# print(f\"Detailed system versioning of the development stack:\\n{pd.show_versions()}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"e1\"></a>\n",
    "## Load data sets\n",
    "- All the data processing functions are organized in the module `data_pipeline`\n",
    "- We could choose to load the entire dataset -- or only a subset of the data for the ease of prototyping and testing \n",
    "  - When subsetting the patient data from the diagnosis and treatment table, it's convenient as a default to subset only patients (Patient_id) that appear in both tables. Later on, when predicting the health status by prescriptions, we want to ensure that each patient has (some) records in both table for the purpose of training statistical models.\n",
    "  - It's important to always check missing values (this can be achieved via `fraction_rows_missing`)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> Load a subset of the patient data ...\n",
      "> Num of patients in diagnosis table: 1000\n",
      "\n",
      "> Load the entire data set ...\n",
      "> size of diagnosis table: 660092\n",
      "> size of treatment table: 1024029\n",
      "> size of ccs lookup     : 72167\n",
      "> Num of patients in diagnosis table: 84059\n",
      "> Num of patients in treatment table: 82546\n"
     ]
    }
   ],
   "source": [
    "# from data_pipeline import load_data, fraction_rows_missing\n",
    "\n",
    "# data sets: Diagnosis.csv Prescriptions.csv  ccs.csv\n",
    "input_dir = os.getcwd()\n",
    "diagnosis_file = \"Diagnosis.csv\"\n",
    "treatment_file = \"Prescriptions.csv\"\n",
    "resource_file = \"ccs.csv\"\n",
    "diagnosis_path = os.path.join(input_dir, diagnosis_file)  \n",
    "treatment_path = os.path.join(input_dir, treatment_file) \n",
    "resource_path = os.path.join(input_dir, resource_file) \n",
    "col_key = 'Patient_id'\n",
    "col_date = 'Diag_date'\n",
    "col_code = 'ICD10'\n",
    "\n",
    "n_samples = 1000\n",
    "\n",
    "print(\"> Load a subset of the patient data ...\") # by default, only those that appear in both diagnosis and treatment tables)\n",
    "df_diag, df_treat, df_res = load_data(input_dir=os.getcwd(), n=n_samples, dropna=False, verbose=False)\n",
    "assert len(df_diag[col_key].unique()) == n_samples\n",
    "assert set(df_treat[col_key].unique()) == set(df_diag[col_key].unique())\n",
    "print(f\"> Num of patients in diagnosis table: {len(df_diag[col_key].unique())}\")\n",
    "\n",
    "print()\n",
    "print(\"> Load the entire data set ...\")\n",
    "df_diag, df_treat, df_res = load_data(input_dir=os.getcwd(), subset=False, dropna=False, verbose=True)\n",
    "print(f\"> Num of patients in diagnosis table: {len(df_diag[col_key].unique())}\")\n",
    "print(f\"> Num of patients in treatment table: {len(df_treat[col_key].unique())}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"e2\"></a>\n",
    "## Explore data sets\n",
    "    - Examine each patient attribute using appropriate visualization methods\n",
    "    - Answer a few patient-specific queries to better understand the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> size of diagnosis table: 660092\n",
      "> size of treatment table: 1024029\n",
      "> size of ccs lookup     : 72167\n",
      "\n",
      "(fraction_rows_missing) Rows with nulls (n=6):\n",
      "Patient_id Diag_date    ICD10\n",
      "    P02662       NaN    Z04.1\n",
      "    P11855       NaN   Z12.11\n",
      "    P13678       NaN  L03.818\n",
      "    P24482       NaN    K76.0\n",
      "    P27885       NaN  M05.731\n",
      "    P58187       NaN T78.1XXA\n",
      "\n",
      "> Ratio of rows with nulls in diagnosis: 9.09e-06, N=6\n",
      "> Ratio of rows with nulls in treatment table: 0, N=0\n",
      "> Ratio of rows with nulls in CCS table: 0, N=0\n",
      "\n",
      "> size(df_diag): 660092 -> 660086; dropped 6 rows\n",
      "> size(df_treat): 1024029 -> 1024029; dropped 0 rows\n",
      "> size of diagnosis table: 660086\n",
      "> size of treatment table: 1024029\n",
      "> size of ccs lookup     : 72167\n",
      "> Sample size drops from 660092 to 660086\n"
     ]
    }
   ],
   "source": [
    "df_diag, df_treat, df_res = load_data(input_dir=os.getcwd(), subset=False, dropna=False, verbose=True)\n",
    "Nd0, Nt0, Nr0 = df_diag.shape[0], df_treat.shape[0], df_res.shape[0]\n",
    "print()\n",
    "\n",
    "# Check missing values \n",
    "r_missing = fraction_rows_missing(df_diag, verbose=True)\n",
    "print(f\"> Ratio of rows with nulls in diagnosis: {r_missing:.3g}, N={int(r_missing * Nd0)}\") # 9.09e-06\n",
    "r_missing = fraction_rows_missing(df_treat, verbose=True)\n",
    "print(f\"> Ratio of rows with nulls in treatment table: {r_missing:.3g}, N={int(r_missing * Nt0)}\") # 0 \n",
    "r_missing = fraction_rows_missing(df_res, verbose=True)\n",
    "print(f\"> Ratio of rows with nulls in CCS table: {r_missing:.3g}, N={int(r_missing * Nt0)}\") # 0 \n",
    "\n",
    "print()\n",
    "\n",
    "# Now load only rows without missing values (this is a default behavior)\n",
    "df_diag, df_treat, df_res = load_data(input_dir=os.getcwd(), verbose=True)\n",
    "r_missing = fraction_rows_missing(df_treat, verbose=True)\n",
    "\n",
    "# only diagnosis table has missing values\n",
    "for name, df in [('diagnosis', df_diag), ('treatment', df_treat), ('CCS', df_res), ]:\n",
    "    assert fraction_rows_missing(df) == 0, \\\n",
    "        \"Found missing values in {} table. R(missing)={}\".format(name, r_missing)\n",
    "\n",
    "print(f\"> Sample size drops from {Nd0} to {df_diag.shape[0]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Patient_id</th>\n",
       "      <th>Diag_date</th>\n",
       "      <th>ICD10</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>39935</th>\n",
       "      <td>P06014</td>\n",
       "      <td>2018-03-30</td>\n",
       "      <td>M25.569</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50168</th>\n",
       "      <td>P07441</td>\n",
       "      <td>2018-03-22</td>\n",
       "      <td>Z96.1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>353643</th>\n",
       "      <td>P53291</td>\n",
       "      <td>2017-08-22</td>\n",
       "      <td>S51.851A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245448</th>\n",
       "      <td>P36622</td>\n",
       "      <td>2017-10-28</td>\n",
       "      <td>I10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185858</th>\n",
       "      <td>P27611</td>\n",
       "      <td>2016-04-04</td>\n",
       "      <td>I10</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       Patient_id   Diag_date     ICD10\n",
       "39935      P06014  2018-03-30   M25.569\n",
       "50168      P07441  2018-03-22     Z96.1\n",
       "353643     P53291  2017-08-22  S51.851A\n",
       "245448     P36622  2017-10-28       I10\n",
       "185858     P27611  2016-04-04       I10"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_diag.sample(n=5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Patient_id</th>\n",
       "      <th>Prescription_date</th>\n",
       "      <th>drug_category</th>\n",
       "      <th>drug_group</th>\n",
       "      <th>drug_class</th>\n",
       "      <th>drug_code</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>370570</th>\n",
       "      <td>P44710</td>\n",
       "      <td>2016-08-19</td>\n",
       "      <td>Calcium Channel Blockers</td>\n",
       "      <td>Calcium Channel Blockers</td>\n",
       "      <td>Calcium Channel Blockers</td>\n",
       "      <td>D-183</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183549</th>\n",
       "      <td>P12356</td>\n",
       "      <td>2015-02-17</td>\n",
       "      <td>Anticonvulsants</td>\n",
       "      <td>Anticonvulsants - Misc.</td>\n",
       "      <td>Anticonvulsants - Misc.</td>\n",
       "      <td>D-69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224226</th>\n",
       "      <td>P61683</td>\n",
       "      <td>2018-05-14</td>\n",
       "      <td>Antineoplastics and Adjunctive Therapies</td>\n",
       "      <td>Antimetabolites</td>\n",
       "      <td>Antimetabolites</td>\n",
       "      <td>D-92</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>872159</th>\n",
       "      <td>P47530</td>\n",
       "      <td>2016-10-09</td>\n",
       "      <td>Antidepressants</td>\n",
       "      <td>Serotonin Modulators</td>\n",
       "      <td>Serotonin Modulators</td>\n",
       "      <td>D-523</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79821</th>\n",
       "      <td>P22844</td>\n",
       "      <td>2016-12-26</td>\n",
       "      <td>Adhd/Anti-narcolepsy/Anti-obesity/Anorexiants</td>\n",
       "      <td>Amphetamines</td>\n",
       "      <td>Amphetamine Mixtures</td>\n",
       "      <td>D-27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143705</th>\n",
       "      <td>P73970</td>\n",
       "      <td>2016-10-12</td>\n",
       "      <td>Antihypertensives</td>\n",
       "      <td>Antiadrenergic Antihypertensives</td>\n",
       "      <td>Antiadrenergics - Peripherally Acting</td>\n",
       "      <td>D-56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331157</th>\n",
       "      <td>P03695</td>\n",
       "      <td>2016-09-23</td>\n",
       "      <td>Ophthalmic Agents</td>\n",
       "      <td>Beta-Blockers - Ophthalmic</td>\n",
       "      <td>Beta-Blockers - Ophthalmic Combinations</td>\n",
       "      <td>D-161</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>799532</th>\n",
       "      <td>P16036</td>\n",
       "      <td>2015-07-28</td>\n",
       "      <td>Ulcer Drugs</td>\n",
       "      <td>Proton Pump Inhibitors</td>\n",
       "      <td>Proton Pump Inhibitors</td>\n",
       "      <td>D-489</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>859408</th>\n",
       "      <td>P40360</td>\n",
       "      <td>2017-05-02</td>\n",
       "      <td>Antidepressants</td>\n",
       "      <td>Selective Serotonin Reuptake Inhibitors (SSRIs)</td>\n",
       "      <td>Selective Serotonin Reuptake Inhibitors (SSRIs)</td>\n",
       "      <td>D-519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>749622</th>\n",
       "      <td>P28485</td>\n",
       "      <td>2017-01-07</td>\n",
       "      <td>Analgesics - Opioid</td>\n",
       "      <td>Opioid Combinations</td>\n",
       "      <td>Opioid Combinations</td>\n",
       "      <td>D-432</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       Patient_id Prescription_date  \\\n",
       "370570     P44710        2016-08-19   \n",
       "183549     P12356        2015-02-17   \n",
       "224226     P61683        2018-05-14   \n",
       "872159     P47530        2016-10-09   \n",
       "79821      P22844        2016-12-26   \n",
       "143705     P73970        2016-10-12   \n",
       "331157     P03695        2016-09-23   \n",
       "799532     P16036        2015-07-28   \n",
       "859408     P40360        2017-05-02   \n",
       "749622     P28485        2017-01-07   \n",
       "\n",
       "                                        drug_category  \\\n",
       "370570                       Calcium Channel Blockers   \n",
       "183549                                Anticonvulsants   \n",
       "224226       Antineoplastics and Adjunctive Therapies   \n",
       "872159                                Antidepressants   \n",
       "79821   Adhd/Anti-narcolepsy/Anti-obesity/Anorexiants   \n",
       "143705                              Antihypertensives   \n",
       "331157                              Ophthalmic Agents   \n",
       "799532                                    Ulcer Drugs   \n",
       "859408                                Antidepressants   \n",
       "749622                            Analgesics - Opioid   \n",
       "\n",
       "                                             drug_group  \\\n",
       "370570                         Calcium Channel Blockers   \n",
       "183549                          Anticonvulsants - Misc.   \n",
       "224226                                  Antimetabolites   \n",
       "872159                             Serotonin Modulators   \n",
       "79821                                      Amphetamines   \n",
       "143705                 Antiadrenergic Antihypertensives   \n",
       "331157                       Beta-Blockers - Ophthalmic   \n",
       "799532                           Proton Pump Inhibitors   \n",
       "859408  Selective Serotonin Reuptake Inhibitors (SSRIs)   \n",
       "749622                              Opioid Combinations   \n",
       "\n",
       "                                             drug_class drug_code  \n",
       "370570                         Calcium Channel Blockers     D-183  \n",
       "183549                          Anticonvulsants - Misc.      D-69  \n",
       "224226                                  Antimetabolites      D-92  \n",
       "872159                             Serotonin Modulators     D-523  \n",
       "79821                              Amphetamine Mixtures      D-27  \n",
       "143705            Antiadrenergics - Peripherally Acting      D-56  \n",
       "331157          Beta-Blockers - Ophthalmic Combinations     D-161  \n",
       "799532                           Proton Pump Inhibitors     D-489  \n",
       "859408  Selective Serotonin Reuptake Inhibitors (SSRIs)     D-519  \n",
       "749622                              Opioid Combinations     D-432  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Check missing data \n",
    "# r_missing = fraction_rows_missing(df_treat)\n",
    "# assert r_missing == 0, \"Found missing values. R(missing)={}\".format(r_missing)\n",
    "\n",
    "df_treat.sample(n=10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>diag</th>\n",
       "      <th>diag_desc</th>\n",
       "      <th>ccs_1_desc</th>\n",
       "      <th>ccs_2_desc</th>\n",
       "      <th>ccs_3_desc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>59193</th>\n",
       "      <td>T458X2D</td>\n",
       "      <td>Poisn by oth prim sys and hematolog agents, sl...</td>\n",
       "      <td>Mental Illness</td>\n",
       "      <td>Suicide and intentional self-inflicted injury ...</td>\n",
       "      <td>Suicide and intentional self-inflicted injury</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>699</th>\n",
       "      <td>B2701</td>\n",
       "      <td>Gammaherpesviral mononucleosis with polyneurop...</td>\n",
       "      <td>Diseases of the nervous system and sense organs</td>\n",
       "      <td>Other nervous system disorders [95.]</td>\n",
       "      <td>Other nervous system disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32349</th>\n",
       "      <td>S4411XA</td>\n",
       "      <td>Injury of median nerve at upper arm level, rig...</td>\n",
       "      <td>Injury and poisoning</td>\n",
       "      <td>Other injuries and conditions due to external ...</td>\n",
       "      <td>Other injuries and conditions due to external ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27582</th>\n",
       "      <td>S270XXA</td>\n",
       "      <td>Traumatic pneumothorax, initial encounter</td>\n",
       "      <td>Injury and poisoning</td>\n",
       "      <td>Crushing injury or internal injury [234.]</td>\n",
       "      <td>Crushing injury or internal injury</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5331</th>\n",
       "      <td>H018</td>\n",
       "      <td>Other specified inflammations of eyelid</td>\n",
       "      <td>Diseases of the nervous system and sense organs</td>\n",
       "      <td>Eye disorders</td>\n",
       "      <td>Inflammation; infection of eye (except that ca...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          diag                                          diag_desc  \\\n",
       "59193  T458X2D  Poisn by oth prim sys and hematolog agents, sl...   \n",
       "699      B2701  Gammaherpesviral mononucleosis with polyneurop...   \n",
       "32349  S4411XA  Injury of median nerve at upper arm level, rig...   \n",
       "27582  S270XXA          Traumatic pneumothorax, initial encounter   \n",
       "5331      H018            Other specified inflammations of eyelid   \n",
       "\n",
       "                                            ccs_1_desc  \\\n",
       "59193                                   Mental Illness   \n",
       "699    Diseases of the nervous system and sense organs   \n",
       "32349                             Injury and poisoning   \n",
       "27582                             Injury and poisoning   \n",
       "5331   Diseases of the nervous system and sense organs   \n",
       "\n",
       "                                              ccs_2_desc  \\\n",
       "59193  Suicide and intentional self-inflicted injury ...   \n",
       "699                 Other nervous system disorders [95.]   \n",
       "32349  Other injuries and conditions due to external ...   \n",
       "27582          Crushing injury or internal injury [234.]   \n",
       "5331                                       Eye disorders   \n",
       "\n",
       "                                              ccs_3_desc  \n",
       "59193      Suicide and intentional self-inflicted injury  \n",
       "699                       Other nervous system disorders  \n",
       "32349  Other injuries and conditions due to external ...  \n",
       "27582                 Crushing injury or internal injury  \n",
       "5331   Inflammation; infection of eye (except that ca...  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Check missing data \n",
    "# r_missing = fraction_rows_missing(df_res)\n",
    "# assert r_missing == 0, \"Found missing values. R(missing)={}\".format(r_missing)\n",
    "\n",
    "df_res.sample(n=5)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"e3\"></a>\n",
    "### Understand the patient cohort\n",
    "- Unique patients\n",
    "   - Is the set of patient IDs in the treatment/prescription table a subset of those in the diagosis table? No\n",
    "   - how many patients went untreated (or at least treatment not observed in the data set)?\n",
    "     - Number of patients in both diagnosis and treatment: 66608\n",
    "     - Approximately 80% (0.7924) of the patients in diagnosis table also have treatment data\n",
    "- Statistics on diagnosis dates and treatment dates \n",
    "- Statistics on other diagnosis and treatment attributes \n",
    "   - unique ICD codes\n",
    "   - any ill-formatted codes? Yes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> Total unique patitent IDs in diagnosis table: 84059\n",
      "> Total unique patient IDs in treatment table: 82546\n",
      "> n(overlap): 66608, ratio wrt diag: 0.7923958172236167\n",
      "> PatientIDs in treatment is a subset of those in diagnosis? No\n",
      "> Num of patients diagnosed but untreated: 17451\n",
      "> Num of patients treated but undiagnosed: 15938\n"
     ]
    }
   ],
   "source": [
    "col_id = 'Patient_id' \n",
    "uniq_patient_ids_diag = df_diag[col_id].unique()\n",
    "uniq_patient_ids_treat = df_treat[col_id].unique()\n",
    "n_uniq_pids_diag, n_uniq_pids_treat = len(uniq_patient_ids_diag), len(uniq_patient_ids_treat)\n",
    "print(f\"> Total unique patitent IDs in diagnosis table: {len(uniq_patient_ids_diag)}\")\n",
    "print(f\"> Total unique patient IDs in treatment table: {len(uniq_patient_ids_treat)}\")\n",
    "\n",
    "# the set of(unique) patients in diagnosis table who also appear in treatment table\n",
    "set_patients_diag_treat = list(set(uniq_patient_ids_diag).intersection(uniq_patient_ids_treat))\n",
    "print(f\"> n(overlap): {len(set_patients_diag_treat)}, ratio wrt diag: {len(set_patients_diag_treat)/n_uniq_pids_diag}\")\n",
    "\n",
    "# For those who were treated, can we identify all of them in the diagnosis table? \n",
    "is_treated_found_in_diag = set(uniq_patient_ids_treat) <= set(uniq_patient_ids_diag)\n",
    "print(f\"> PatientIDs in treatment is a subset of those in diagnosis? {'Yes' if is_treated_found_in_diag else 'No'}\")\n",
    "\n",
    "# Some patients with diagnoses did not get treated (or at least not recorded in the treatment table)\n",
    "patients_diagnosed_untreated = set(uniq_patient_ids_diag) - set(uniq_patient_ids_treat)\n",
    "print(f\"> Num of patients diagnosed but untreated: {len(patients_diagnosed_untreated)}\")\n",
    "\n",
    "patients_diagnosed_undiagnosed = set(uniq_patient_ids_treat) - set(uniq_patient_ids_diag)\n",
    "print(f\"> Num of patients treated but undiagnosed: {len(patients_diagnosed_undiagnosed)}\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"e4\"></a>\n",
    "### Now, let's look at the date attributes: `Diag_date` and `Prescription_date`\n",
    "  - A reasonable assumption is that a treatment generally comes after (some) diagnoses, but does it hold true in this dataset?\n",
    "  - We'll begin by defining some useful utility functions"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "  \n",
    "### Observe the relationship between patients and their first diagnois dates vs treatment/prescription dates\n",
    "\n",
    "The relationship between the diagnosis date and the prescription date will be important later on when we try to predict health status (or disease states) via prescriptions; in particular, we may want to ensure that we only use __relevant prescriptions to predict a particular diagnosis__\n",
    "  - How do we sort out the prescription relevancy? The answer is **temporal alignment**. Assuming that prescriptions are given to treat one or more diseases as represented by one or more ICD10 codes, then for each ICD10 and its diagnosis date (d), we can define the time window W centered on d, such that the W encloses d and is not too \"wide.\" \n",
    "    - In a typical healthcare process, a prescription drug could be given prior to a diagnosis, say 60 days (e.g. the patient already had the health issue prior to the visit); on the other hand, prescription drugs are usually given following a diagnosis up to say 30 days and then the patient has to do a follow-up visit in order to get another set of prescriptions\n",
    "\n",
    "#### Definition: Temporal Alignment\n",
    "\n",
    "Denote a prescription by *p* and a diagnosis by *d*. Further let the date of a prescription be given by *t(p)* and the diagnosis date given by *t(d)*. Then, a prescription (p) is temporally aligned with a diagnosis (d) with respect to a time window *W = \\[w1, w2\\]* iff t(p) >= t(d)-w1 and t(p) <= t(d)+w2 (i.e. t(p) falls within the interval W)\n",
    "- I am abusing the notation. *t(d)* can be viewed as function of *d*, or simply t subscript d\n",
    "\n",
    "- Using the observation given above, we can then set W = (60, 60), which allows us to focus only on the prescriptions as early as 60 days prior to the **target diagnosis** and as late as 60 days following the diagnosis.\n",
    "  - Certainly, the best interval depends both on the clinical condition and the treatment\n",
    "\n",
    "#### Observations\n",
    "- As can be seen from the example J06.9 (Acute upper respiratory infection, unspecified), we can find a subset of patients (approximately ~119 out of the 1500 patients) who had prescriptions matching the diagnosis given by W = (60, 60)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> size(df_diag): 660092 -> 660086; dropped 6 rows\n",
      "> size(df_treat): 1024029 -> 1024029; dropped 0 rows\n",
      "> size of diagnosis table: 13598\n",
      "> size of treatment table: 21106\n",
      "> size of ccs lookup     : 72167\n",
      "(match) Total number of patients: 1500\n",
      "(match) Number of patients with diagnosis J06.9: 131\n",
      "(match) Number of patients who had been given prescriptions for diagnosis J06.9: 131\n",
      "... n(diagnosed): 131 >=? n(treated): 131\n",
      "(match) diagnosis table with the window of dates determined (W=(60, 60)):\n",
      "Index(['Patient_id', 'Diag_date', 'ICD10', 'Diag_min', 'Diag_max'], dtype='object')\n",
      "\n",
      "... sampled dataframe:\n",
      "+--------------+-------------+---------+------------+------------+\n",
      "| Patient_id   | Diag_date   | ICD10   | Diag_min   | Diag_max   |\n",
      "|--------------+-------------+---------+------------+------------|\n",
      "| P01734       | 2017-05-31  | J06.9   | 2017-04-01 | 2017-07-30 |\n",
      "| P01734       | 2018-05-15  | J06.9   | 2018-03-16 | 2018-05-15 |\n",
      "| P01769       | 2017-03-04  | J06.9   | 2017-01-03 | 2017-05-03 |\n",
      "| P01776       | 2018-01-16  | J06.9   | 2017-11-17 | 2018-03-17 |\n",
      "| P02131       | 2018-03-28  | J06.9   | 2018-01-27 | 2018-05-15 |\n",
      "| P02131       | 2018-04-01  | J06.9   | 2018-01-31 | 2018-05-15 |\n",
      "| P02880       | 2016-03-11  | J06.9   | 2016-01-11 | 2016-05-10 |\n",
      "| P04841       | 2016-09-01  | J06.9   | 2016-07-03 | 2016-10-31 |\n",
      "| P05720       | 2015-12-15  | J06.9   | 2015-10-16 | 2016-02-13 |\n",
      "| P06881       | 2016-09-04  | J06.9   | 2016-07-06 | 2016-11-03 |\n",
      "+--------------+-------------+---------+------------+------------+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/pleiades/Documents/work/interview/Merck/utils.py:335: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df[col] = s.apply(lambda x: x[i])\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(match) Found n=120 patients with matching prescription records\n",
      "> Patient ID: P02131\n",
      "     Diag_date Prescription_date drug_code\n",
      "23  2018-03-28        2018-03-28     D-134\n",
      "24  2018-03-28        2018-04-01     D-146\n",
      "25  2018-03-28        2018-02-19     D-303\n",
      "26  2018-03-28        2018-02-19     D-393\n",
      "27  2018-03-28        2018-04-01     D-399\n",
      "28  2018-03-28        2018-03-07     D-430\n",
      "29  2018-04-01        2018-03-28     D-134\n",
      "30  2018-04-01        2018-04-01     D-146\n",
      "31  2018-04-01        2018-02-19     D-303\n",
      "32  2018-04-01        2018-02-19     D-393\n",
      "33  2018-04-01        2018-04-01     D-399\n",
      "34  2018-04-01        2018-03-07     D-430\n",
      "> Patient ID: P06881\n",
      "     Diag_date Prescription_date drug_code\n",
      "60  2016-09-04        2016-09-04      D-25\n",
      "61  2016-09-04        2016-10-16     D-156\n",
      "62  2016-09-04        2016-10-16     D-287\n",
      "63  2016-09-04        2016-10-22     D-536\n",
      "> Patient ID: P13228\n",
      "      Diag_date Prescription_date drug_code\n",
      "118  2017-02-14        2017-02-14     D-134\n",
      "119  2017-02-14        2017-02-14     D-146\n",
      "120  2017-02-14        2017-02-28     D-159\n",
      "> Patient ID: P19603\n",
      "      Diag_date Prescription_date drug_code\n",
      "203  2018-03-16        2018-04-10      D-45\n",
      "204  2018-03-16        2018-03-16     D-146\n",
      "205  2018-03-16        2018-03-16     D-206\n",
      "206  2018-03-16        2018-04-07     D-206\n",
      "207  2018-03-16        2018-04-01     D-303\n",
      "208  2018-03-16        2018-04-27     D-303\n",
      "209  2018-03-16        2018-03-02     D-303\n",
      "> Patient ID: P21859\n",
      "      Diag_date Prescription_date drug_code\n",
      "219  2017-12-12        2018-01-30      D-25\n",
      "220  2017-12-12        2017-10-31      D-91\n",
      "221  2017-12-12        2017-12-24      D-91\n",
      "222  2017-12-12        2018-01-13      D-91\n",
      "223  2017-12-12        2017-11-26      D-91\n",
      "224  2017-12-12        2018-01-13     D-153\n",
      "225  2017-12-12        2017-11-26     D-153\n",
      "226  2017-12-12        2017-10-31     D-153\n",
      "227  2017-12-12        2017-10-31     D-159\n",
      "228  2017-12-12        2018-01-13     D-159\n",
      "229  2017-12-12        2017-11-26     D-159\n",
      "230  2017-12-12        2017-12-24     D-159\n",
      "> Patient ID: P40535\n",
      "      Diag_date Prescription_date drug_code\n",
      "326  2016-05-18        2016-05-18     D-136\n",
      "327  2016-05-18        2016-05-18     D-146\n",
      "328  2016-05-18        2016-05-16     D-163\n",
      "329  2016-05-18        2016-04-12     D-163\n",
      "330  2016-05-18        2016-05-05     D-229\n",
      "331  2016-05-18        2016-04-12     D-275\n",
      "332  2016-05-18        2016-05-18     D-287\n",
      "> Patient ID: P60363\n",
      "      Diag_date Prescription_date drug_code\n",
      "527  2017-04-16        2017-04-22     D-146\n",
      "528  2017-04-16        2017-02-15     D-155\n",
      "529  2017-04-16        2017-06-03     D-155\n",
      "530  2017-04-16        2017-06-01     D-287\n",
      "531  2017-04-16        2017-03-20     D-394\n",
      "532  2017-04-16        2017-04-02     D-519\n",
      "> Patient ID: P60412\n",
      "      Diag_date Prescription_date drug_code\n",
      "537  2017-09-21        2017-09-21     D-349\n",
      "> Patient ID: P82887\n",
      "      Diag_date Prescription_date drug_code\n",
      "723  2016-02-17        2016-02-17      D-25\n",
      "724  2016-02-17        2016-02-17     D-287\n",
      "725  2016-02-17        2016-02-17     D-410\n",
      "> Patient ID: P84382\n",
      "      Diag_date Prescription_date drug_code\n",
      "728  2018-02-27        2018-03-11      D-27\n",
      "729  2018-02-27        2018-02-27     D-399\n",
      "730  2018-02-27        2018-04-15     D-519\n",
      "731  2018-02-27        2018-02-21     D-519\n"
     ]
    }
   ],
   "source": [
    "# from utils import match\n",
    "from data_pipeline import intersection\n",
    "\n",
    "dp = Diagnosis.properties\n",
    "col_key = dp['id']\n",
    "col_date = dp['date']\n",
    "col_code = dp['code']\n",
    "\n",
    "tp = Treatment.properties\n",
    "col_date_t = tp['date']\n",
    "col_class_t = tp['class']  # drug class\n",
    "col_code_t = tp['code']\n",
    "\n",
    "n_samples = 1500\n",
    "# Get diagnosis and treatment table (subsampling if n_samples is given)\n",
    "########################################################\n",
    "df_diag, df_treat, df_res = load_data(input_dir=os.getcwd(), n=n_samples, verbose=True)\n",
    "if n_samples is None:  # need to ensure that we take only patients that appear in both tables\n",
    "    set_patients = intersection(df_diag, df_treat, on='Patient_id') \n",
    "    n_samples = len(set_patients)\n",
    "    df_diag = df_diag[df_diag[col_key].isin(set_patients)]\n",
    "    df_treat = df_treat[df_treat[col_key].isin(set_patients)]\n",
    "else: \n",
    "    # if n_samples is not None, it's guaranteed that patients in set_patients appear in both table\n",
    "    set_patients = df_diag[col_key].unique() \n",
    "\n",
    "N_diag = len(df_diag[col_key].unique()) \n",
    "N_treat = len(df_treat[col_key].unique()) \n",
    "assert N_diag == len(set_patients) <= n_samples, f\"N_diag: {N_diag} =?= {len(set_patients)} <=? {n_samples}\"\n",
    "assert N_treat == len(set_patients) <= n_samples, f\"N_treat: {N_treat} =?= {len(set_patients)} <=? {n_samples}\"\n",
    "########################################################\n",
    "\n",
    "is_prescription_encoded = col_code_t in df_treat.columns\n",
    "# print(f\"> col(df_treat): {df_treat.columns}\")\n",
    "\n",
    "target_codes = ['J06.9', ]\n",
    "W = (60, 60)  # select a window \n",
    "for target_code in target_codes: \n",
    "    df_match = match(df_diag, df_treat, target_code, window=W, verbose=1)\n",
    "\n",
    "    # pick a random n patients and observe their respective diagnosis and prescription dates (which should satisfy\n",
    "    # the date constraints)\n",
    "    n_examples = 10\n",
    "    pids = np.random.choice(df_match[col_key].unique(), n_examples)\n",
    "    for pid, dfi in df_match[df_match[col_key].isin(pids)].groupby(col_key): \n",
    "        print(f\"> Patient ID: {pid}\")\n",
    "        assert not dfi.empty\n",
    "        if is_prescription_encoded: \n",
    "            print(dfi[[col_date, col_date_t, col_code_t]])\n",
    "        else: \n",
    "            print(dfi[[col_date, col_date_t, col_class_t]])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### `Patient_id` vs number of sessions in diagosis table and treatment table\n",
    "- Number of sessions are defined by counting the distinct values of diagosis dates and treatment dates\n",
    "- Sort patients according to the number of sessions in decending order and with the same patient ordering, find their respective numbers of treatment sessions (i.e. number of prescription dates)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1152x576 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1152x576 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from plot_utils import plot_sessions\n",
    "\n",
    "ax = plt.figure().gca()\n",
    "ax.yaxis.set_major_locator(MaxNLocator(integer=True)) # force yticks to use integers\n",
    "\n",
    "# np.random.seed(53)\n",
    "df_diag_sub, df_treat_sub, _ = load_data(input_dir=os.getcwd(), n=50)\n",
    "deidentify = True\n",
    "pids = plot_sessions(df_diag_sub, show_key=deidentify, col='Diag_date', title='Diagnosis')\n",
    "\n",
    "# plot patients (IDs) vs num of sessions according to the order given by the diagnosis table above\n",
    "_ = plot_sessions(df_treat_sub, show_key=deidentify, col='Prescription_date', title='Treatment', pids=pids)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"e5\"></a>\n",
    "### Analyze diagnoses in terms of ICDs across different time stamps (or sessions)  \n",
    "\n",
    "Utilities of analyzing ICD10 codes are given the module `icd_utils`\n",
    "\n",
    "- Below is an example EDA session to verify ICD10 codes given in the diagnosis table\n",
    "  - Number of unique codes: 14257\n",
    "  - Are there any ill-formatted codes? Yes, n=14\n",
    "  - Number of codes not found in CCS? n=83\n",
    "\n",
    "##### Observations  \n",
    "- There are totally 83 codes not found in CCS. Let's refer to each of these codes as a \"miss\" for simplicity. \n",
    "  - Among these misses, a large fraction of them seem to be valid ICD10 codes; we could verify them individually and choose to keep them in the analysis. However, for the purpose of a prototype, we could also ignore them temporarily because their ratio is low.\n",
    "  - Some of the misses may be ICD-9, which can be converted to ICD-10 with appropriate software. \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(1) Number of unique codes: 14257\n",
      "(2) Invalid codes (n=14):\n",
      "['999.99', '999.9', '036.8130', 'KHD.X', '000', '309.28', '281', '411', '742.3', 'MHD.X', '065.5', '327.23', '167.1', '000.0']\n",
      "\n",
      "(3) Num of codes not found in CCS (n=83):\n",
      "['I83.89', 'Z12.1', 'S30.0', 'C44.5', 'S02.612', 'S93.401', 'S92.11A', 'S69.91', 'S80.211', '999.99', 'V50.9', 'K52.80', 'S92.352', '000.0', 'R20', 'Z80.401', '167.1', '742.3', 'M25.11', 'H40.113', 'S99', 'R51.67', 'T42.0', 'S83.501', 'E07.8', 'V70.0', 'N04.59', 'H10.42', 'Q33.5XX1', 'M75.12', 'I83.8', '999.9', 'N30.4', 'M97.645', 'O47.88', 'H66.3', 'M21.61', 'S83.512', '000', 'K11.2', 'Z00.0', 'O29', 'S00.06', 'H10.2', 'C47.03', 'D37.0', 'M75.11', 'B08', '065.5', 'O26.2', 'R29.70', 'S73', 'M20.1', 'N64.80', 'Z00.1', 'J45.90', 'S90.112', 'KHD.X', 'M35.0', 'R88.82', '327.23', 'V22.1', 'Z01.41', '411', 'Z48.81', 'MHD.X', 'F04.2', 'S27.00XX', 'C50.91', '281', 'S86.011', 'H40.133', 'S76.111', '309.28', 'H90.1', 'M11.16', 'F78.4', 'S00', 'S42.413', 'J45.4', '036.8130', 'K59.0', 'J01.1']\n",
      "\n",
      "(3.1) Codes missed by CCS must be invalid? True\n",
      "(5) List example ICDs across sessions ...\n",
      "\n",
      "... PID=P00001\n",
      "... date: Diag_date\n",
      "... dfi:\n",
      "   Patient_id   Diag_date    ICD10\n",
      "0      P00001  2015-12-06    N92.6\n",
      "1      P00001  2015-12-06  O26.842\n",
      "2      P00001  2015-12-13  O26.842\n",
      "3      P00001  2016-02-29  O26.843\n",
      "4      P00001  2016-03-27  O26.843\n",
      "5      P00001  2016-04-03  O26.843\n",
      "6      P00001  2016-04-10  O26.843\n",
      "7      P00001  2016-04-11  O26.843\n",
      "8      P00001  2016-04-13   O34.21\n",
      "9      P00001  2016-04-13      O80\n",
      "10     P00001  2016-04-13   Z38.01\n",
      "11     P00001  2016-04-14   Z38.01\n",
      "12     P00001  2016-04-15   Z38.01\n",
      "13     P00001  2016-04-16   Z38.01\n",
      "14     P00001  2016-04-17   Z38.01\n",
      "\n",
      "... PID=P00002\n",
      "... date: Diag_date\n",
      "... dfi:\n",
      "   Patient_id   Diag_date    ICD10\n",
      "15     P00002  2016-02-23   Z82.49\n",
      "16     P00002  2017-01-31   F43.20\n",
      "17     P00002  2017-01-31   Z00.00\n",
      "18     P00002  2017-05-19    R07.9\n",
      "19     P00002  2017-05-20   R07.89\n",
      "20     P00002  2017-06-05  I25.118\n",
      "\n",
      "... PID=P00003\n",
      "... date: Diag_date\n",
      "... dfi:\n",
      "   Patient_id   Diag_date   ICD10\n",
      "21     P00003  2017-07-26  M20.22\n",
      "22     P00003  2017-08-16  M20.22\n",
      "\n",
      "... PID=P00004\n",
      "... date: Diag_date\n",
      "... dfi:\n",
      "   Patient_id   Diag_date   ICD10\n",
      "23     P00004  2018-03-16  Z00.00\n",
      "24     P00004  2018-03-19   Z11.1\n",
      "\n",
      "... PID=P00005\n",
      "... date: Diag_date\n",
      "... dfi:\n",
      "   Patient_id   Diag_date    ICD10\n",
      "25     P00005  2018-02-13  G43.909\n",
      "26     P00005  2018-02-14  G43.001\n",
      "\n",
      "... PID=P00006\n",
      "... date: Diag_date\n",
      "... dfi:\n",
      "   Patient_id   Diag_date   ICD10\n",
      "27     P00006  2016-03-29  R07.89\n",
      "28     P00006  2016-04-02  Z00.00\n",
      "29     P00006  2016-04-25  R06.02\n",
      "30     P00006  2016-04-26  R09.82\n",
      "31     P00006  2016-06-05   E03.9\n",
      "32     P00006  2016-06-05   E78.2\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Import relevant libraries, classes and utilty functions\n",
    "from data_pipeline import analyze_diagnosis\n",
    "\n",
    "df_diag, codebook = analyze_diagnosis(verbose=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> Code missed 999.99: 591\n",
      "> Code missed KHD.X: 35\n",
      "> Code missed 000: 21\n",
      "> Code missed S00.06: 12\n",
      "> Code missed K59.0: 6\n",
      "> Code missed S86.011: 4\n",
      "> Code missed Z01.41: 3\n",
      "> Code missed Z00.0: 2\n",
      "> Code missed Z00.1: 2\n",
      "> Code missed J45.90: 2\n",
      "> Code missed V22.1: 2\n",
      "> Code missed MHD.X: 2\n",
      "> Code missed S27.00XX: 2\n",
      "> Code missed 309.28: 2\n",
      "> Code missed I83.89: 1\n",
      "> Code missed Z12.1: 1\n",
      "> Code missed S30.0: 1\n",
      "> Code missed C44.5: 1\n",
      "> Code missed S02.612: 1\n",
      "> Code missed S93.401: 1\n"
     ]
    }
   ],
   "source": [
    "codes_missed = codebook['missed']\n",
    "code_counts = collections.Counter(dict(df_diag[col_code].value_counts())) \n",
    "\n",
    "# Among all the codes that are missed by CCS, list their documentation frequencies: \n",
    "# Are they simply errors, systematic anomelies, or perhaps \"valid\" but not in ICD10?\n",
    "for code in sorted(codes_missed, key=lambda x: code_counts[x], reverse=True)[:20]:\n",
    "    code_eff = decode(code)\n",
    "    assert code_eff in code_counts, \"code {} not found\".format(code_eff)\n",
    "    print(f\"> Code missed {code_eff}: {code_counts[code_eff]}\") \n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q1a\"></a>\n",
    "### From diagnosis codes to defining health status\n",
    "\n",
    "##### Observations \n",
    "- Some of the CSS-missed codes (or simply \"misses\") are actually documented quite often (e.g. 999.99 has 591 mentions, where 999.99 could be an mis-coded ICD-9 code) \n",
    "- Some of the misses are legit even though they are not found in the CCS table (i.e. `df_res`)\n",
    "  - e.g. J45.90: unspecified asthma \n",
    "- Some high-frequency ICD10 codes do not necessarily represent a health status per se but represent external factors (e.g. lab tests, symptoms) linked to the health status or disease state. E.g. Z00.00 (Encntr for general adult medical exam w/o abnormal findings) has over 20K mentions in the data set (`df_diag`) but __it is not a direct description of a health status and therefore by itself does not say much about a patient's clinical conditions.__\n",
    "  - E.g. R05 (Cough), is a symptom\n",
    "  - ICD10 codes that are alphanumerically larger than **O00** are often not disease-specific coding according to their [standard categorization](https://www.medicalbillingandcoding.org/icd-10-cm/)\n",
    " \n",
    "- Some disease-specific ICD10 codes are mentioned very frequently because they are often concomitant relative to something more critical. E.g. I10 (hypertension) has 16315 mentions but it may be a comorbid condition to diabetes, CKD, etc.\n",
    "   - As will be discussed shortly, we can sort the ICD10 codes according to their associated time stamps and thereby form a diagnosis-specific temporal sequence, which can give us a quick overview of how the patient's disease state progresses over time. This will serve as a basis for computing signficance of each diagnosis later on.\n",
    "   - E.g. Patient (ID=*P52427*) has the diagnosis sequence *`R05 I10 J45.40 K76.0 R10.13 I10 K57.92 K57.92 K57.92 R10.30`*, where **J45.40 (asthma)** could be the primary diagnosis, for which **I10** is a correlated condition and thus tends to co-occur often with J45.40, i.e. patients with asthma are more likely to develop hypertension (see [this paper](https://www.nejm.org/doi/full/10.1056/NEJMra1800345) for more details)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>diag</th>\n",
       "      <th>diag_desc</th>\n",
       "      <th>ccs_1_desc</th>\n",
       "      <th>ccs_2_desc</th>\n",
       "      <th>ccs_3_desc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>22550</th>\n",
       "      <td>R0609</td>\n",
       "      <td>Other forms of dyspnea</td>\n",
       "      <td>Diseases of the respiratory system</td>\n",
       "      <td>Other lower respiratory disease [133.]</td>\n",
       "      <td>Other lower respiratory disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71018</th>\n",
       "      <td>Z1211</td>\n",
       "      <td>Encounter for screening for malignant neoplasm...</td>\n",
       "      <td>Symptoms; signs; and ill-defined conditions an...</td>\n",
       "      <td>Factors influencing health care</td>\n",
       "      <td>Other screening for suspected conditions (not ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71141</th>\n",
       "      <td>Z23</td>\n",
       "      <td>Encounter for immunization</td>\n",
       "      <td>Infectious and parasitic diseases</td>\n",
       "      <td>Immunizations and screening for infectious dis...</td>\n",
       "      <td>Immunizations and screening for infectious dis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71408</th>\n",
       "      <td>Z4732</td>\n",
       "      <td>Aftercare following explantation of hip joint ...</td>\n",
       "      <td>Symptoms; signs; and ill-defined conditions an...</td>\n",
       "      <td>Factors influencing health care</td>\n",
       "      <td>Other aftercare</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        diag                                          diag_desc  \\\n",
       "22550  R0609                             Other forms of dyspnea   \n",
       "71018  Z1211  Encounter for screening for malignant neoplasm...   \n",
       "71141    Z23                         Encounter for immunization   \n",
       "71408  Z4732  Aftercare following explantation of hip joint ...   \n",
       "\n",
       "                                              ccs_1_desc  \\\n",
       "22550                 Diseases of the respiratory system   \n",
       "71018  Symptoms; signs; and ill-defined conditions an...   \n",
       "71141                  Infectious and parasitic diseases   \n",
       "71408  Symptoms; signs; and ill-defined conditions an...   \n",
       "\n",
       "                                              ccs_2_desc  \\\n",
       "22550             Other lower respiratory disease [133.]   \n",
       "71018                    Factors influencing health care   \n",
       "71141  Immunizations and screening for infectious dis...   \n",
       "71408                    Factors influencing health care   \n",
       "\n",
       "                                              ccs_3_desc  \n",
       "22550                    Other lower respiratory disease  \n",
       "71018  Other screening for suspected conditions (not ...  \n",
       "71141  Immunizations and screening for infectious dis...  \n",
       "71408                                    Other aftercare  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Example codes that are (probably) not disease-specific but relevant external factors \n",
    "# (e.g. medical procedures) linked to the patient's health conditions. \n",
    "codes_aux = ['R0609', 'Z4732', 'Z1211', 'Z23']\n",
    "df_res[df_res['diag'].isin(codes_aux)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>diag</th>\n",
       "      <th>diag_desc</th>\n",
       "      <th>ccs_1_desc</th>\n",
       "      <th>ccs_2_desc</th>\n",
       "      <th>ccs_3_desc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8532</th>\n",
       "      <td>I10</td>\n",
       "      <td>Essential (primary) hypertension</td>\n",
       "      <td>Diseases of the circulatory system</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>Essential hypertension</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14772</th>\n",
       "      <td>M542</td>\n",
       "      <td>Cervicalgia</td>\n",
       "      <td>Diseases of the musculoskeletal system and con...</td>\n",
       "      <td>Spondylosis; intervertebral disc disorders; ot...</td>\n",
       "      <td>Spondylosis; intervertebral disc disorders; ot...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       diag                         diag_desc  \\\n",
       "8532    I10  Essential (primary) hypertension   \n",
       "14772  M542                       Cervicalgia   \n",
       "\n",
       "                                              ccs_1_desc  \\\n",
       "8532                  Diseases of the circulatory system   \n",
       "14772  Diseases of the musculoskeletal system and con...   \n",
       "\n",
       "                                              ccs_2_desc  \\\n",
       "8532                                        Hypertension   \n",
       "14772  Spondylosis; intervertebral disc disorders; ot...   \n",
       "\n",
       "                                              ccs_3_desc  \n",
       "8532                              Essential hypertension  \n",
       "14772  Spondylosis; intervertebral disc disorders; ot...  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Example codes that are likely to be comorbid conditions (rather than the main diagnosis)\n",
    "_, _, df_res = load_data(input_dir=os.getcwd(), subset=False, verbose=0)\n",
    "codes_secondary = ['I10', 'M542']\n",
    "df_res[df_res['diag'].isin(codes_secondary)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> Found 14243 valid ICD10 codes.\n",
      "> Found 7852 disease-specific codes (ratio: 0.5512883521729972)\n",
      "> examples:\n",
      "['C81.74', 'M71.579', 'N44.1', 'T43.011A', 'N82.3', 'G91.0', 'T45.1X5D', 'D80.2', 'T38.4X5S', 'F40.11']\n",
      "\n",
      "\n",
      "> 1. Most popular diagnosis codes ...\n",
      "> Z00.00 (freq=23987): ['Encntr for general adult medical exam w/o abnormal findings']\n",
      "> I10 (freq=16315): ['Essential (primary) hypertension']\n",
      "> Z01.419 (freq=12624): ['Encntr for gyn exam (general) (routine) w/o abn findings']\n",
      "> Z12.31 (freq=8870): ['Encntr screen mammogram for malignant neoplasm of breast']\n",
      "> M54.5 (freq=8410): ['Low back pain']\n",
      "> Z00.129 (freq=7805): ['Encntr for routine child health exam w/o abnormal findings']\n",
      "> J06.9 (freq=7766): ['Acute upper respiratory infection, unspecified']\n",
      "> Z23 (freq=6889): ['Encounter for immunization']\n",
      "> J02.9 (freq=6174): ['Acute pharyngitis, unspecified']\n",
      "> E11.9 (freq=6043): ['Type 2 diabetes mellitus without complications']\n",
      "> R05 (freq=5567): ['Cough']\n",
      "> R07.9 (freq=4361): ['Chest pain, unspecified']\n",
      "> Z00.01 (freq=3960): ['Encounter for general adult medical exam w abnormal findings']\n",
      "> M54.2 (freq=3880): ['Cervicalgia']\n",
      "> J30.1 (freq=3767): ['Allergic rhinitis due to pollen']\n",
      "\n",
      "> 2. Most popular disease-specific diagnosis codes ...\n",
      "> I10 (freq=16315): ['Essential (primary) hypertension']\n",
      "> M54.5 (freq=8410): ['Low back pain']\n",
      "> J06.9 (freq=7766): ['Acute upper respiratory infection, unspecified']\n",
      "> J02.9 (freq=6174): ['Acute pharyngitis, unspecified']\n",
      "> E11.9 (freq=6043): ['Type 2 diabetes mellitus without complications']\n",
      "> M54.2 (freq=3880): ['Cervicalgia']\n",
      "> J30.1 (freq=3767): ['Allergic rhinitis due to pollen']\n",
      "> G47.33 (freq=3733): ['Obstructive sleep apnea (adult) (pediatric)']\n",
      "> N39.0 (freq=3592): ['Urinary tract infection, site not specified']\n",
      "> J01.90 (freq=3477): ['Acute sinusitis, unspecified']\n",
      "> E11.65 (freq=3407): ['Type 2 diabetes mellitus with hyperglycemia']\n",
      "> E78.5 (freq=3373): ['Hyperlipidemia, unspecified']\n",
      "> E03.9 (freq=3180): ['Hypothyroidism, unspecified']\n",
      "> L70.0 (freq=3006): ['Acne vulgaris']\n",
      "> J20.9 (freq=3000): ['Acute bronchitis, unspecified']\n",
      "\n",
      "> ID:      P13075\n",
      "> history: 175 days\n",
      "> sequence:\n",
      "K57.30 K57.32 K57.90 R19.8 Z45.2 K57.32 K57.32 K57.32 K57.32 K57.32 M10.00 K57.32\n",
      "\n",
      "> ID:      P40128\n",
      "> history: 67 days\n",
      "> sequence:\n",
      "I10 I10\n",
      "\n",
      "> ID:      P43465\n",
      "> history: 177 days\n",
      "> sequence:\n",
      "H25.043 I62.9\n",
      "\n",
      "> ID:      P62527\n",
      "> history: 82 days\n",
      "> sequence:\n",
      "L65.9 Z00.00 I10 Z12.31 I10 N85.8 N92.1 I10\n",
      "\n",
      "> ID:      P74779\n",
      "> history: 147 days\n",
      "> sequence:\n",
      "K29.70 K86.2 I10 R22.42 K74.60 K74.60 K74.69 E11.29\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# top 10 diagnosis codes\n",
    "codes_valid = codebook['valid'] # set(codes) - set(codes_invalid)\n",
    "codes_disease = codebook['disease']\n",
    "print(f\"> Found {len(codes_valid)} valid ICD10 codes.\")\n",
    "print(f\"> Found {len(codes_disease)} disease-specific codes (ratio: {len(codes_disease)/len(codes_valid)})\")\n",
    "print(f\"> examples:\\n{list(codes_valid)[:10]}\\n\")\n",
    "print()\n",
    "\n",
    "topn = 15\n",
    "print(f\"> 1. Most popular diagnosis codes ...\") # remember to call encode() before table lookup!!! \n",
    "for code in sorted(codes_valid, key=lambda x: code_counts[x], reverse=True)[:topn]: \n",
    "    print(f\"> {code} (freq={code_counts[code]}): {df_res[df_res['diag']==encode(code)]['diag_desc'].values}\")\n",
    "\n",
    "print()\n",
    "print(f\"> 2. Most popular disease-specific diagnosis codes ...\")\n",
    "for code in sorted(codes_disease, key=lambda x: code_counts[x], reverse=True)[:topn]: \n",
    "    print(f\"> {code} (freq={code_counts[code]}): {df_res[df_res['diag']==encode(code)]['diag_desc'].values}\")\n",
    "    \n",
    "# Among all the patients with I10 (hypertension), can we find \n",
    "# a reasonable primary diagnosis for which hypertension could be just a concomitant condition (e.g. CKD, diabetes)? \n",
    "print()\n",
    "codes_secondary = ['I10', 'M54.2']\n",
    "n_samples = 5\n",
    "pids = df_diag[df_diag[col_code].isin(codes_secondary)][col_key].unique()\n",
    "pids = np.random.choice(pids, min(n_samples, len(pids)))\n",
    "df_seq = transform_diagnosis(df_diag[df_diag[col_key].isin(pids)])\n",
    "col_key, col_date, col_code, *_ = df_diag.columns\n",
    "col_intv = 'History'\n",
    "for pid, row in df_seq.iterrows(): \n",
    "    print(f\"> ID:      {row[col_key]}\")\n",
    "    print(f\"> history: {row[col_intv]} days\")\n",
    "    print(f\"> sequence:\\n{row[col_code]}\\n\")\n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q1b\"></a>\n",
    "### Observing patients and their diagnoses as temporal sequences\n",
    "- How long are their medical histories? \n",
    "- List all the diagnoses and their dates from the first session to the last\n",
    "\n",
    "#### Observations\n",
    "- The longest medical history is 1339 days long\n",
    "- (Most) patients tend to have very different diagnoses at different times throughout their medical history. To characterize a patient's health status or disease state, we would want to focus on: \n",
    "   - 1) Recency or temporal locality (e.g. most recent 180 days): Adjustable depending on the chronicity of the disease. \n",
    "   - 2) The degree of importance for a given diagnosis (as proxy-represented by one or more ICD10 codes): In particular, the **\"importance weight\"** of an ICD code is related to their **recency**, **frequency** and **specificity** for an individual's disease state. Assuming that the recency is already being qualified by 1), we can determine the importance weight of an ICD10 code by **some function of a ICD10's documentation frequency** -- and how \"special\" this diagnosis is to a particular patient. Why? \n",
    "      - Two patients X and Y may share similar overall diagnoses (e.g. they both have hypertension, or I10, frequently occurred in their records); however, their primary diagnoses may be quite different. E.g. X could be a patient with CKD as the main health issue, whereas Y has been a long-term type 2 diabetes patient, both are at higher risk of experiencing hypertension episodes or even cardiovascular conditions. \n",
    "   - 3) As mentioned earlier, some ICD codes are not directly indicative of a health status while others may be comorbid conditions (i.e. not primary diagnoses to be informative for defining health status).\n",
    "       \n",
    "Note that the aforementioned criteria (i.e. temperal locality and frequency) are just an approximation to the patient's true disease state. The \"true\" disease state is actually a __time series__ and therefore it changes over time. \n",
    "\n",
    "To consider a more precise characterization of a patient's health status, we can also consider the temporal sequence of ICD10 codes obtained from the most recent medical history (e.g. codes assigned during the past 180 days) as an even better approximation for a patient's disease state, given that the ordering of diagnoses could serve as a __proxy representation for disease progression__. \n",
    "\n",
    "As can be observed from the data, most patients tend to have more than one ICD10 code documented in their records, which could be **i) a recurrent health condition ii) the same condition with a different severity stage (hence a different ICD code) iii) comorbid conditions for a primary diagnosis -- or iv) simply a new diagnosis reflecting a new episode of pathologically different heath condition than those from the past. Any new ICD assignment may or may not be relevant to his/her old conditions.** \n",
    "- E.g. Among those patients with COPD (J44.9), we could very well observe multiple other diagnosis codes (that tend to co-occur with the primary diagnosis) such as i) J42 (unspecified chronic bronchitis) as a comorbid condition ii) tobacco use (Z72.0), as a another external factor that would affect the health status ... //this is my own example, not what's being observed in this data set\n",
    "\n",
    "Not all diagnosis codes represent diseases but they can be symptoms, abnormal lab findgs, injuries, and other factors that affect health status but nonetheless, they do not represent \"heatlh status\" by themselves. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from utils import demo_sequencing, subsample_seq\n",
    "from IPython.display import clear_output\n",
    "\n",
    "sample_size = 1000\n",
    "df_seq = demo_sequencing(dtype='diag', verbose=1)\n",
    "\n",
    "print()\n",
    "df_diag, df_treat, df_res = load_data(input_dir=os.getcwd(), subset=False, verbose=False)\n",
    "pids_anomely = ['P00021', ]\n",
    "for r, row in df_diag[df_diag[col_key].isin(pids_anomely)].iterrows(): \n",
    "    print(row)\n",
    "# clear_output(wait=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q1c\"></a>\n",
    "### Sequencing diagnosis and loading sequenced data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from utils import subsample_seq\n",
    "\n",
    "df_diag = Diagnosis.load(dtype='in', subset=False, verbose=0)\n",
    "Np = len(df_diag[col_key].unique())\n",
    "tLoad = True\n",
    "\n",
    "diag = Diagnosis() # create a Diagnosis object\n",
    "if tLoad: \n",
    "    df_seq = Diagnosis.load(dtype='seq') # load the pre-computed sequence data, because it's take a minute or two to sequence the data\n",
    "else: \n",
    "    diag.init(**kargs) # ensure that 'diag' is hooked to the diagnosis table\n",
    "    df_seq = diag.sequence(tFilterByICD=True, tFilterByLength=True, n_days_lookback=180)\n",
    "    # note: set tFilterByICD to True to only include valid (well-formatted) ICD10 codes\n",
    "    #       set tFilterByLength to False to include the entire d-sequence for each patient\n",
    "    #       Say you want to focus on only the most recent 100 days of diagnoses, then pass \n",
    "    #       n_days_lookback=100\n",
    "    \n",
    "Ns = len(df_seq[col_key].unique())\n",
    "print(f\"Number of (unique) patients in original data: {Np}, in sequenced file: {Ns} | {Np} >=? {Ns}\")\n",
    "print(f\"Longest length of medical records (days): {df_seq[col_intv].max()}\")\n",
    "\n",
    "print(f\"\\nShow example d-sequences ...\")\n",
    "subsample_seq(df_seq, n=10, verbose=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q1d\"></a>\n",
    "### Diagonsis sequence, disease progression and health status \n",
    "- Since each patient can have a long medical history, which equates to a long time series of diagnosis. The diagonsis sequence sheds light on how a disease progresses over time and thereby defining health status, which is time-varying.\n",
    "- We can simplify the representation of the diagnosis time series by representing them as a temporally ordered sequence of diagnosis codes like so: `L57.8 M25.512 S43.085A S43.085A S43.085A S43.085A S43.085A S43.085A`\n",
    "- To distinguish between primary and secondary diagnoses as pertaining to comorbid conditions, domain knowledge is often required but we could apply simple heurstics to tease out the main diagnoses\n",
    "  \n",
    "- We will use TF-IDF as an example measure of diagnostic importance via the following steps: \n",
    "  - First, we represent each patient in terms of a temporally-ordered diagnostic sequence, which we will refer to as simply -- diagnositic sequence, or d-sequence. \n",
    "  - Treat each d-sequence as a (patient) document\n",
    "  - Compute a TF-IDF score for each ICD10 associated with a d-sequence\n",
    "    - Intuitively, ICD10 codes that occur frequently in a d-sequence are important because they have high \"term frequencies (TFs)\" \n",
    "    - However, the ICD10 codes that are individually important for a patient should be clinically more important than those that tend to occur in different patients' diagnoses (common comorbid conditions, seasonal flu, etc.); this is measured by ICD10's inverse document frequencies (IDFs)\n",
    "\n",
    "<a name=\"q1e\"></a>\n",
    "### Using the primary diagnoses (plural) to characterize health status\n",
    "- We could pick the top-n ICD codes with the highest importance score (e.g. TF-IDF score) as the primary diagnoses\n",
    "  - Note that this should be considered as **an approximation to a patient's true health status** (although diagnosis codes themselves are merely a proxy to a patient's health status because they are not always accurate)\n",
    "  - D-sequence contains more information about a patient's health status but in order to use prescriptions to predict health status, d-sequence is not as simple to model as a \"label.\" \n",
    "  - Later on, by representing prescriptions as temperal sequences like a d-sequence, it's also possible to apply sequence models (e.g. seq2seq, Siamese networks) to predict the health status encoded by d-sequences; however, in this prototype, we shall consider simpler methods"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Representing patients by their d-sequences\n",
    "- As mentioned before, recency is an important factor for qualifying a patient's health status; from the EDA, we know that the longest medical history in this dataset is over 3 years (1300+ days), which is perhaps too long to be factored in a patient's health status.  \n",
    "- In the following demo, we shall consider the **truncated d-sequence** for each patient (180 days), out of which we then compute the importance score for each ICD code. \n",
    "  - Alternatively, pass different values to `n_days_lookback` parameter (as an argument for `Diagnosis.sequence()`) to truncate the older segment of the d-sequence at varying degrees. For instance, if you want to focus on only the most recent 60 days of diagnoses, then specify `n_days_lookback=60` also in `Diagnosis.sequence()`. Patients with predominently acute conditions would be good use cases for a more restrictive constraint. \n",
    "  - Diagnosis dates are lost in d-sequence by default (only the ordering is preserved). If you wish to include time stamps in the d-sequence, please set `tIncludeTime` to True. \n",
    "  - The `History` attribute in the resulting d-sequence dataframe (`df_seq`) is measured in **days**. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Estimating the most important diagnoses\n",
    "- Compute the top-n most important diagnoses according to a given measure (e.g. TF-IDF) \n",
    "- We'll apply TF-IDF on d-sequences as a measure of importance\n",
    "  - The top-n ICD10 codes, where n=3 in the following demo, are considered as the most representative diagonses that collectively describe a patient's health status"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Diagnosis] Loading sequenced diagnosis file from:\n",
      "/Users/pleiades/Documents/work/interview/Merck/Diagnosis-sequenced.csv\n",
      "\n",
      "(eval_topn_features) Nd: 84051, dim(Xtr): (84051, 11863), size(vocab): 11863\n",
      "... example feature names (n=11863=?=11863):\n",
      "['A02.0', 'A03.8', 'A04.0', 'A04.1', 'A04.4', 'A04.5', 'A04.7', 'A04.71', 'A04.72', 'A04.8', 'A04.9', 'A05.8', 'A05.9', 'A06.0', 'A06.9', 'A07.1', 'A07.3', 'A07.8', 'A08.0', 'A08.11', 'A08.19', 'A08.2', 'A08.39', 'A08.4', 'A08.8', 'A09', 'A15.0', 'A15.6', 'A15.7', 'A15.9', 'A150', 'A17.81', 'A18.4', 'A26.0', 'A28.1', 'A31.0', 'A31.9', 'A35', 'A37.00', 'A37.90', 'A38.8', 'A38.9', 'A40.1', 'A40.8', 'A40.9', 'A41.01', 'A41.02', 'A41.1', 'A41.50', 'A41.51']\n",
      "['Z95.4', 'Z95.5', 'Z95.810', 'Z95.811', 'Z95.818', 'Z95.820', 'Z95.828', 'Z95.9', 'Z96.0', 'Z96.1', 'Z96.22', 'Z96.41', 'Z96.5', 'Z96.60', 'Z96.611', 'Z96.612', 'Z96.622', 'Z96.641', 'Z96.642', 'Z96.643', 'Z96.649', 'Z96.651', 'Z96.652', 'Z96.653', 'Z96.659', 'Z96.7', 'Z96.81', 'Z96.9', 'Z97.10', 'Z97.3', 'Z97.5', 'Z97.8', 'Z98.0', 'Z98.1', 'Z98.2', 'Z98.41', 'Z98.51', 'Z98.52', 'Z98.61', 'Z98.62', 'Z98.811', 'Z98.818', 'Z98.82', 'Z98.84', 'Z98.86', 'Z98.89', 'Z98.890', 'Z98.891', 'Z99.11', 'Z99.81']\n",
      "\n",
      "--- doc #11109 ---\n",
      "   feature  score\n",
      "0  Z01.419    1.0\n",
      "...... top N(3) features: Z01.419\n",
      "\n",
      "--- doc #23794 ---\n",
      "  feature  score\n",
      "0  Z00.00    1.0\n",
      "...... top N(3) features: Z00.00\n",
      "\n",
      "--- doc #24446 ---\n",
      "  feature  score\n",
      "0     I10    1.0\n",
      "...... top N(3) features: I10\n",
      "\n",
      "--- doc #26997 ---\n",
      "  feature     score\n",
      "0   D59.4  0.542917\n",
      "1   D58.0  0.524015\n",
      "2   D59.9  0.510604\n",
      "...... top N(3) features: D59.4 D58.0 D59.9\n",
      "\n",
      "--- doc #37658 ---\n",
      "  feature  score\n",
      "0     Z23    1.0\n",
      "...... top N(3) features: Z23\n",
      "\n",
      "--- doc #55292 ---\n",
      "  feature     score\n",
      "0   E29.9  0.645367\n",
      "1  H00.11  0.519681\n",
      "2  D22.30  0.481650\n",
      "...... top N(3) features: E29.9 H00.11 D22.30\n",
      "\n",
      "--- doc #57472 ---\n",
      "  feature  score\n",
      "0   E03.9    1.0\n",
      "...... top N(3) features: E03.9\n",
      "\n",
      "--- doc #69369 ---\n",
      "   feature  score\n",
      "0  Z00.129    1.0\n",
      "...... top N(3) features: Z00.129\n",
      "\n",
      "--- doc #75296 ---\n",
      "   feature     score\n",
      "0  M67.911  0.583284\n",
      "1   K70.30  0.524527\n",
      "2  D61.818  0.308749\n",
      "...... top N(3) features: M67.911 K70.30 D61.818\n",
      "\n",
      "--- doc #81402 ---\n",
      "  feature  score\n",
      "0     C73    1.0\n",
      "...... top N(3) features: C73\n",
      "\n",
      "(eval_topn_features) top N features overall across all docs ...\n",
      "... doc(mean):\n",
      "   feature     score\n",
      "0   Z00.00  0.070945\n",
      "1  Z01.419  0.036782\n",
      "2      I10  0.033008\n",
      "3  Z00.129  0.028271\n",
      "4    J06.9  0.024895\n",
      "5      Z23  0.021805\n",
      "6    J02.9  0.020129\n",
      "7   Z12.31  0.019765\n",
      "8      R05  0.015207\n",
      "9   Z00.01  0.014022\n",
      "\n",
      "> There are n=10678 (unique) primary diagnosis codes in total.\n",
      "> Most common primary diagnosis: Z00.00, n=8834\n",
      "> Least common primary diagnosis: O65.5, n=1\n",
      "> size(df_diag): 660092 -> 660086; dropped 6 rows\n",
      "> size(df_treat): 1024029 -> 1024029; dropped 0 rows\n",
      "> size of diagnosis table: 660086\n",
      "> size of treatment table: 1024029\n",
      "> size of ccs lookup     : 72167\n",
      "> Most most common conditions:\n",
      "['I10' 'J06.9' 'J02.9' 'E11.9' 'M54.5' 'J01.90' 'J20.9' 'E78.5' 'N39.0'\n",
      " 'E03.9' 'L70.0' 'E11.65' 'E78.2' 'J02.0' 'J30.9' 'J11.1' 'F41.9' 'J01.00'\n",
      " 'K21.9' 'M54.2']\n",
      "\n",
      "+--------+---------+-------------------------------------------------------------+\n",
      "| code   |   count | code_desc                                                   |\n",
      "|--------+---------+-------------------------------------------------------------|\n",
      "| I10    |    3766 | Essential (primary) hypertension                            |\n",
      "| J06.9  |    2795 | Acute upper respiratory infection, unspecified              |\n",
      "| J02.9  |    2257 | Acute pharyngitis, unspecified                              |\n",
      "| E11.9  |    1446 | Type 2 diabetes mellitus without complications              |\n",
      "| M54.5  |    1282 | Low back pain                                               |\n",
      "| J01.90 |    1252 | Acute sinusitis, unspecified                                |\n",
      "| J20.9  |    1076 | Acute bronchitis, unspecified                               |\n",
      "| E78.5  |    1041 | Hyperlipidemia, unspecified                                 |\n",
      "| N39.0  |     954 | Urinary tract infection, site not specified                 |\n",
      "| E03.9  |     887 | Hypothyroidism, unspecified                                 |\n",
      "| L70.0  |     883 | Acne vulgaris                                               |\n",
      "| E11.65 |     784 | Type 2 diabetes mellitus with hyperglycemia                 |\n",
      "| E78.2  |     732 | Mixed hyperlipidemia                                        |\n",
      "| J02.0  |     717 | Streptococcal pharyngitis                                   |\n",
      "| J30.9  |     691 | Allergic rhinitis, unspecified                              |\n",
      "| J11.1  |     627 | Flu due to unidentified influenza virus w oth resp manifest |\n",
      "| F41.9  |     618 | Anxiety disorder, unspecified                               |\n",
      "| J01.00 |     597 | Acute maxillary sinusitis, unspecified                      |\n",
      "| K21.9  |     591 | Gastro-esophageal reflux disease without esophagitis        |\n",
      "| M54.2  |     588 | Cervicalgia                                                 |\n",
      "+--------+---------+-------------------------------------------------------------+\n",
      "> Least common conditions:\n",
      "['H95.89' 'F19.24' 'D47.9' 'H02.004' 'F12.90' 'G47.11' 'M08.00' 'E34.4'\n",
      " 'F10.29' 'G40.822' 'F19.17' 'I31.8' 'H35.30' 'M05.59' 'H68.101' 'M10.271'\n",
      " 'H20.13' 'G40.804' 'B25.1' 'M21061']\n",
      "\n",
      "+---------+---------+--------------------------------------------------------------+\n",
      "| code    |   count | code_desc                                                    |\n",
      "|---------+---------+--------------------------------------------------------------|\n",
      "| H95.89  |       1 | Oth postproc comp and disorders of the ear/mastd, NEC        |\n",
      "| F19.24  |       1 | Oth psychoactive substance dependence w mood disorder        |\n",
      "| D47.9   |       1 | Neoplm of uncrt behav of lymphoid,hematpoetc & rel tiss,unsp |\n",
      "| H02.004 |       1 | Unspecified entropion of left upper eyelid                   |\n",
      "| F12.90  |       1 | Cannabis use, unspecified, uncomplicated                     |\n",
      "| G47.11  |       1 | Idiopathic hypersomnia with long sleep time                  |\n",
      "| M08.00  |       1 | Unsp juvenile rheumatoid arthritis of unspecified site       |\n",
      "| E34.4   |       1 | Constitutional tall stature                                  |\n",
      "| F10.29  |       1 | Alcohol dependence with unspecified alcohol-induced disorder |\n",
      "| G40.822 |       1 | Epileptic spasms, not intractable, w/o status epilepticus    |\n",
      "| F19.17  |       1 | Oth psychoactive substance abuse w persisting dementia       |\n",
      "| I31.8   |       1 | Other specified diseases of pericardium                      |\n",
      "| H35.30  |       1 | Unspecified macular degeneration                             |\n",
      "| M05.59  |       1 | Rheumatoid polyneuropathy w rheumatoid arthritis mult site   |\n",
      "| H68.101 |       1 | Unspecified obstruction of Eustachian tube, right ear        |\n",
      "| M10.271 |       1 | Drug-induced gout, right ankle and foot                      |\n",
      "| H20.13  |       1 | Chronic iridocyclitis, bilateral                             |\n",
      "| G40.804 |       1 | Other epilepsy, intractable, without status epilepticus      |\n",
      "| B25.1   |       1 | Cytomegaloviral hepatitis                                    |\n",
      "| M21061  |       1 | n/a                                                          |\n",
      "+---------+---------+--------------------------------------------------------------+\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(       code  count                                          code_desc\n",
       " 15      I10   3766                   Essential (primary) hypertension\n",
       " 24    J06.9   2795     Acute upper respiratory infection, unspecified\n",
       " 33    J02.9   2257                     Acute pharyngitis, unspecified\n",
       " 18    E11.9   1446     Type 2 diabetes mellitus without complications\n",
       " 91    M54.5   1282                                      Low back pain\n",
       " 73   J01.90   1252                       Acute sinusitis, unspecified\n",
       " 136   J20.9   1076                      Acute bronchitis, unspecified\n",
       " 108   E78.5   1041                        Hyperlipidemia, unspecified\n",
       " 47    N39.0    954        Urinary tract infection, site not specified\n",
       " 156   E03.9    887                        Hypothyroidism, unspecified\n",
       " 102   L70.0    883                                      Acne vulgaris\n",
       " 344  E11.65    784        Type 2 diabetes mellitus with hyperglycemia\n",
       " 25    E78.2    732                               Mixed hyperlipidemia\n",
       " 332   J02.0    717                          Streptococcal pharyngitis\n",
       " 27    J30.9    691                     Allergic rhinitis, unspecified\n",
       " 379   J11.1    627  Flu due to unidentified influenza virus w oth ...\n",
       " 149   F41.9    618                      Anxiety disorder, unspecified\n",
       " 158  J01.00    597             Acute maxillary sinusitis, unspecified\n",
       " 394   K21.9    591  Gastro-esophageal reflux disease without esoph...\n",
       " 370   M54.2    588                                        Cervicalgia,\n",
       "          code  count                                          code_desc\n",
       " 4861   H95.89      1  Oth postproc comp and disorders of the ear/mas...\n",
       " 6965   F19.24      1  Oth psychoactive substance dependence w mood d...\n",
       " 6966    D47.9      1  Neoplm of uncrt behav of lymphoid,hematpoetc &...\n",
       " 6967  H02.004      1         Unspecified entropion of left upper eyelid\n",
       " 6977   F12.90      1           Cannabis use, unspecified, uncomplicated\n",
       " 6980   G47.11      1        Idiopathic hypersomnia with long sleep time\n",
       " 6989   M08.00      1  Unsp juvenile rheumatoid arthritis of unspecif...\n",
       " 6998    E34.4      1                        Constitutional tall stature\n",
       " 7006   F10.29      1  Alcohol dependence with unspecified alcohol-in...\n",
       " 7014  G40.822      1  Epileptic spasms, not intractable, w/o status ...\n",
       " 7017   F19.17      1  Oth psychoactive substance abuse w persisting ...\n",
       " 7023    I31.8      1            Other specified diseases of pericardium\n",
       " 7027   H35.30      1                   Unspecified macular degeneration\n",
       " 7030   M05.59      1  Rheumatoid polyneuropathy w rheumatoid arthrit...\n",
       " 7031  H68.101      1  Unspecified obstruction of Eustachian tube, ri...\n",
       " 7032  M10.271      1            Drug-induced gout, right ankle and foot\n",
       " 7034   H20.13      1                   Chronic iridocyclitis, bilateral\n",
       " 7038  G40.804      1  Other epilepsy, intractable, without status ep...\n",
       " 7043    B25.1      1                          Cytomegaloviral hepatitis\n",
       " 7047   M21061      1                                                n/a)"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from utils import demo_topn_diagnoses\n",
    "demo_topn_diagnoses(topn=20)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2a\"></a>\n",
    "### Analyzing prescription data\n",
    "- There are 604 drug classes, 415 drug groups and 89 drug categories. \n",
    "- Similar to how the diagnosis progression can be captured by the *d-sequence*, we can also define the prescription sequence (or treatment pathway) as the __temporally ordered sequence of prescriptions (or simply denoted as the p-sequence)__. \n",
    "  - The analysis for the treatment/prescription data is similar to the diagnosis table give earlier except that drugs are not coded like ICD10 for diagnosis. \n",
    "  - For the ease of analysis and modeling, we will encode the prescription based on the drug attribute with the most specificity, which is the `drug_class` (|drug_class|=604)\n",
    "  - Given this, we can then define prescription sequence (or *p-sequence*) as the temporally ordered drug codes. \n",
    "\n",
    "- To determine the most important prescription drugs for each patient, we can again apply TF-IDF over the p-sequences to heuristically determine the importance weight for each drug prescription in each patient historical record.\n",
    "  - Doing so could help us potentially reduce the number of prescription variables when building statistical models to predict the health status. \n",
    "  - It's helpful sometimes to consider reducing the number of variables because we may not have sufficient sample sizes in some cases to train a reasonably accurate model with 604 variables.\n",
    "  \n",
    "- For the purpose of this demo, I'll build baseline models (e.g. logistic regression) for a few ICD10 codes (n=10) selected from the most common primary diagnoses, where 'primary' is defined by couting from within the top-n ICD10 codes (n=3) used to represent the health status for each patient. See `utils.demo_topn_diagnoses()` for more details.\n",
    "  - In this demo, I will not choose non-disease-specific ICD10 codes (i.e. most ICD10 codes alphanumerically greater than O00) as targets; intuitively, prescriptions are more correlated to disease-related diagnoses rather than, say, lab tests and misc medical procedures but of course, this hypothesis needs to be verified.\n",
    "  - But in general, we could build a predictive model for all primary diagnoses. \n",
    "  - We can then observe the predictive performances (in F1 score) in these cases.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(1.1) Found n=89 drug categories, and their counts are as follows:\n",
      "Antidepressants                                  92834\n",
      "Antihypertensives                                62022\n",
      "Antihyperlipidemics                              58264\n",
      "Contraceptives                                   51732\n",
      "Antidiabetics                                    49251\n",
      "Dermatologicals                                  40185\n",
      "Anticonvulsants                                  37644\n",
      "Analgesics - Opioid                              34163\n",
      "Thyroid Agents                                   31785\n",
      "Antiasthmatic and Bronchodilator Agents          30977\n",
      "Analgesics - Anti-Inflammatory                   29641\n",
      "Adhd/Anti-narcolepsy/Anti-obesity/Anorexiants    28434\n",
      "Antianxiety Agents                               28018\n",
      "Beta Blockers                                    27910\n",
      "Ulcer Drugs                                      27055\n",
      "Penicillins                                      25007\n",
      "Antivirals                                       24577\n",
      "Calcium Channel Blockers                         20434\n",
      "Diuretics                                        20089\n",
      "Corticosteroids                                  18398\n",
      "Name: drug_category, dtype: int64\n",
      "\n",
      "(1.2) Found n=415 drug groups, and their counts are as follows:\n",
      "Hmg CoA Reductase Inhibitors                       50639\n",
      "Selective Serotonin Reuptake Inhibitors (SSRIs)    47576\n",
      "Combination Contraceptives - Oral                  45042\n",
      "Thyroid Hormones                                   31138\n",
      "Nonsteroidal Anti-Inflammatory Agents (NSAIDs)     26995\n",
      "Anticonvulsants - Misc.                            24836\n",
      "Ace Inhibitors                                     24464\n",
      "Benzodiazepines                                    23120\n",
      "Amphetamines                                       21911\n",
      "Biguanides                                         21436\n",
      "Calcium Channel Blockers                           20434\n",
      "Opioid Combinations                                20302\n",
      "Beta Blockers Cardio-Selective                     20204\n",
      "Proton Pump Inhibitors                             19237\n",
      "Glucocorticosteroids                               18238\n",
      "Antidepressants - Misc.                            17404\n",
      "Angiotensin Ii Receptor Antagonists                17278\n",
      "Sympathomimetics                                   17226\n",
      "Azithromycin                                       16729\n",
      "Antihypertensive Combinations                      16367\n",
      "Name: drug_group, dtype: int64\n",
      "\n",
      "(1.3) Found n=604 drug classes, and their counts are as follows:\n",
      "Hmg CoA Reductase Inhibitors                            50639\n",
      "Selective Serotonin Reuptake Inhibitors (SSRIs)         47576\n",
      "Thyroid Hormones                                        31138\n",
      "Combination Contraceptives - Oral                       30632\n",
      "Nonsteroidal Anti-Inflammatory Agents (NSAIDs)          25367\n",
      "Anticonvulsants - Misc.                                 24836\n",
      "Ace Inhibitors                                          24464\n",
      "Benzodiazepines                                         23120\n",
      "Biguanides                                              21436\n",
      "Calcium Channel Blockers                                20434\n",
      "Beta Blockers Cardio-Selective                          20204\n",
      "Proton Pump Inhibitors                                  19237\n",
      "Glucocorticosteroids                                    18238\n",
      "Antidepressants - Misc.                                 17404\n",
      "Angiotensin Ii Receptor Antagonists                     17278\n",
      "Amphetamine Mixtures                                    16978\n",
      "Azithromycin                                            16729\n",
      "Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)    15059\n",
      "Aminopenicillins                                        14077\n",
      "Nasal Steroids                                          14013\n",
      "Name: drug_class, dtype: int64\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(        Patient_id Prescription_date                            drug_category  \\\n",
       " 0           P04447        2015-07-22     Genitourinary Agents - Miscellaneous   \n",
       " 1           P20764        2016-12-19     Genitourinary Agents - Miscellaneous   \n",
       " 2           P34917        2016-12-17     Genitourinary Agents - Miscellaneous   \n",
       " 3           P18892        2018-02-12     Genitourinary Agents - Miscellaneous   \n",
       " 4           P33131        2018-02-09     Genitourinary Agents - Miscellaneous   \n",
       " ...            ...               ...                                      ...   \n",
       " 1024024     P09160        2016-08-21  Antiasthmatic and Bronchodilator Agents   \n",
       " 1024025     P08970        2016-07-09  Antiasthmatic and Bronchodilator Agents   \n",
       " 1024026     P16202        2017-04-15  Antiasthmatic and Bronchodilator Agents   \n",
       " 1024027     P06670        2016-04-21  Antiasthmatic and Bronchodilator Agents   \n",
       " 1024028     P53711        2018-04-12  Antiasthmatic and Bronchodilator Agents   \n",
       " \n",
       "                            drug_group                    drug_class drug_code  \n",
       " 0        Prostatic Hypertrophy Agents  5-Alpha Reductase Inhibitors       D-0  \n",
       " 1        Prostatic Hypertrophy Agents  5-Alpha Reductase Inhibitors       D-0  \n",
       " 2        Prostatic Hypertrophy Agents  5-Alpha Reductase Inhibitors       D-0  \n",
       " 3        Prostatic Hypertrophy Agents  5-Alpha Reductase Inhibitors       D-0  \n",
       " 4        Prostatic Hypertrophy Agents  5-Alpha Reductase Inhibitors       D-0  \n",
       " ...                               ...                           ...       ...  \n",
       " 1024024                     Xanthines                     Xanthines     D-603  \n",
       " 1024025                     Xanthines                     Xanthines     D-603  \n",
       " 1024026                     Xanthines                     Xanthines     D-603  \n",
       " 1024027                     Xanthines                     Xanthines     D-603  \n",
       " 1024028                     Xanthines                     Xanthines     D-603  \n",
       " \n",
       " [1024029 rows x 6 columns],\n",
       " {'5-Alpha Reductase Inhibitors': 'D-0',\n",
       "  '5-HT3 Receptor Antagonists': 'D-1',\n",
       "  '5-Lipoxygenase Inhibitors': 'D-2',\n",
       "  'Ace Inhibitor & Calcium Channel Blocker Combinations': 'D-3',\n",
       "  'Ace Inhibitors': 'D-4',\n",
       "  'Ace Inhibitors & Thiazide/Thiazide-Like': 'D-5',\n",
       "  'Acne Antibiotics': 'D-6',\n",
       "  'Acne Combinations': 'D-7',\n",
       "  'Acne Products': 'D-8',\n",
       "  'Adhd Agent - Selective Alpha Adrenergic Agonists': 'D-9',\n",
       "  'Adhd Agent - Selective Norepinephrine Reuptake Inhibitor': 'D-10',\n",
       "  'Adrenergic Combinations': 'D-11',\n",
       "  'Agents for External Genital and Perianal Warts': 'D-12',\n",
       "  'Agents for Facial Wrinkles - Retinoids': 'D-13',\n",
       "  'Agents for Gaucher Disease': 'D-14',\n",
       "  'Agents for Pheochromocytoma': 'D-15',\n",
       "  'Alcohol Deterrents': 'D-16',\n",
       "  'Alkylating Agents': 'D-17',\n",
       "  'Alpha 1-Adrenoceptor Antagonists': 'D-18',\n",
       "  'Alpha Adrenergic Agonist & Carbonic Anhydrase Inhib Comb': 'D-19',\n",
       "  'Alpha-2 Receptor Antagonists (Tetracyclics)': 'D-20',\n",
       "  'Alpha-Beta Blockers': 'D-21',\n",
       "  'Alpha-Glucosidase Inhibitors': 'D-22',\n",
       "  'Alpha-Proteinase Inhibitor (Human)': 'D-23',\n",
       "  'Aminoglycosides': 'D-24',\n",
       "  'Aminopenicillins': 'D-25',\n",
       "  'Ampa Glutamate Receptor Antagonists': 'D-26',\n",
       "  'Amphetamine Mixtures': 'D-27',\n",
       "  'Amphetamines': 'D-28',\n",
       "  'Analgesics Other': 'D-29',\n",
       "  'Analgesics-Sedatives': 'D-30',\n",
       "  'Anaphylaxis Therapy Agents': 'D-31',\n",
       "  'Androgen Biosynthesis Inhibitors': 'D-32',\n",
       "  'Androgens': 'D-33',\n",
       "  'Anesthetics Topical Oral': 'D-34',\n",
       "  'Anesthetics Topical Oral - Combinations': 'D-35',\n",
       "  'Angiotensin Ii Receptor Ant-Ca Channel Blocker-Thiazides': 'D-36',\n",
       "  'Angiotensin Ii Receptor Antag & Ca Channel Blocker Comb': 'D-37',\n",
       "  'Angiotensin Ii Receptor Antag & Thiazide/Thiazide-Like': 'D-38',\n",
       "  'Angiotensin Ii Receptor Antagonists': 'D-39',\n",
       "  'Anorexiant Combinations': 'D-40',\n",
       "  'Anorexiants Non-Amphetamine': 'D-41',\n",
       "  'Anthelmintics': 'D-42',\n",
       "  'Anti-Cataplectic Agents': 'D-43',\n",
       "  'Anti-IgE Monoclonal Antibodies': 'D-44',\n",
       "  'Anti-Infective Agents - Misc.': 'D-45',\n",
       "  'Anti-Infective Genitourinary Irrigants': 'D-46',\n",
       "  'Anti-Infective Misc. - Combinations': 'D-47',\n",
       "  'Anti-Infectives - Throat': 'D-48',\n",
       "  'Anti-Inflammatory Agents': 'D-49',\n",
       "  'Anti-Inflammatory Agents - Topical': 'D-50',\n",
       "  'Anti-Inflammatory Combinations - Topical': 'D-51',\n",
       "  'Anti-Obesity - GLP-1 Receptor Agonists': 'D-52',\n",
       "  'Anti-Obesity Agent Combinations': 'D-53',\n",
       "  'Anti-TNF-Alpha - Monoclonal Antibodies': 'D-54',\n",
       "  'Antiadrenergics - Centrally Acting': 'D-55',\n",
       "  'Antiadrenergics - Peripherally Acting': 'D-56',\n",
       "  'Antiandrogens': 'D-57',\n",
       "  'Antianginals-Other': 'D-58',\n",
       "  'Antianxiety Agents - Misc.': 'D-59',\n",
       "  'Antiarrhythmics Type I-A': 'D-60',\n",
       "  'Antiarrhythmics Type I-B': 'D-61',\n",
       "  'Antiarrhythmics Type I-C': 'D-62',\n",
       "  'Antiarrhythmics Type Iii': 'D-63',\n",
       "  'Antibiotic Mixtures Topical': 'D-64',\n",
       "  'Antibiotic Steroid Combinations - Topical': 'D-65',\n",
       "  'Antibiotics - Topical': 'D-66',\n",
       "  'Anticholinergic Combinations': 'D-67',\n",
       "  'Anticonvulsants - Benzodiazepines': 'D-68',\n",
       "  'Anticonvulsants - Misc.': 'D-69',\n",
       "  'Antidepressants - Misc.': 'D-70',\n",
       "  'Antidiarrheal/Probiotic Agents - Misc.': 'D-71',\n",
       "  'Antidotes - Chelating Agents': 'D-72',\n",
       "  'Antidotes and Specific Antagonists': 'D-73',\n",
       "  'Antiemetic Combinations': 'D-74',\n",
       "  'Antiemetics - Anticholinergic': 'D-75',\n",
       "  'Antiemetics - Miscellaneous': 'D-76',\n",
       "  'Antiestrogens': 'D-77',\n",
       "  'Antifungals': 'D-78',\n",
       "  'Antifungals - Topical': 'D-79',\n",
       "  'Antifungals - Topical Combinations': 'D-80',\n",
       "  'Antihemophilic Products': 'D-81',\n",
       "  'Antihistamine-Steroid': 'D-82',\n",
       "  'Antihistamines - Ethanolamines': 'D-83',\n",
       "  'Antihistamines - Non-Sedating': 'D-84',\n",
       "  'Antihistamines - Phenothiazines': 'D-85',\n",
       "  'Antihistamines - Piperidines': 'D-86',\n",
       "  'Antihyperlipidemics - Misc.': 'D-87',\n",
       "  'Antihyperlipidemics Misc. Combinations': 'D-88',\n",
       "  'Antimalarial Combinations': 'D-89',\n",
       "  'Antimalarials': 'D-90',\n",
       "  'Antimanic Agents': 'D-91',\n",
       "  'Antimetabolites': 'D-92',\n",
       "  'Antimyasthenic/Cholinergic Agents': 'D-93',\n",
       "  'Antimycobacterial Agents': 'D-94',\n",
       "  'Antineoplastic - Braf Kinase Inhibitors': 'D-95',\n",
       "  'Antineoplastic - Immunomodulators': 'D-96',\n",
       "  'Antineoplastic - Mek Inhibitors': 'D-97',\n",
       "  'Antineoplastic - Monoclonal Antibodies': 'D-98',\n",
       "  'Antineoplastic - Multikinase Inhibitors': 'D-99',\n",
       "  'Antineoplastic - Proteasome Inhibitors': 'D-100',\n",
       "  'Antineoplastic - Tyrosine Kinase Inhibitors': 'D-101',\n",
       "  'Antineoplastic - mTOR Kinase Inhibitors': 'D-102',\n",
       "  'Antineoplastic Antibiotics': 'D-103',\n",
       "  'Antineoplastic Antimetabolites - Topical': 'D-104',\n",
       "  'Antineoplastic Combinations': 'D-105',\n",
       "  'Antineoplastic or Premalignant Lesions - Topical Misc.': 'D-106',\n",
       "  \"Antineoplastic or Premalignant Lesions - Topical NSAID's\": 'D-107',\n",
       "  'Antineoplastics Misc.': 'D-108',\n",
       "  'Antiparkinson Anticholinergics': 'D-109',\n",
       "  'Antiparkinson Dopaminergics': 'D-110',\n",
       "  'Antiparkinson Monoamine Oxidase Inhibitors': 'D-111',\n",
       "  'Antiperistaltic Agents': 'D-112',\n",
       "  'Antiprotozoal Agents': 'D-113',\n",
       "  'Antipruritics - Topical': 'D-114',\n",
       "  'Antipsoriatics': 'D-115',\n",
       "  'Antipsoriatics - Systemic': 'D-116',\n",
       "  'Antipsychotics - Misc.': 'D-117',\n",
       "  'Antiretroviral Combinations': 'D-118',\n",
       "  'Antiretrovirals - CCR5 Antagonists (Entry Inhibitor)': 'D-119',\n",
       "  'Antiretrovirals - Integrase Inhibitors': 'D-120',\n",
       "  'Antiretrovirals - Protease Inhibitors': 'D-121',\n",
       "  'Antiretrovirals - RTI-Non-Nucleoside Analogues': 'D-122',\n",
       "  'Antiretrovirals - RTI-Nucleoside Analogues-Purines': 'D-123',\n",
       "  'Antiretrovirals - RTI-Nucleoside Analogues-Pyrimidines': 'D-124',\n",
       "  'Antiretrovirals - RTI-Nucleoside Analogues-Thymidines': 'D-125',\n",
       "  'Antiretrovirals - RTI-Nucleotide Analogues': 'D-126',\n",
       "  'Antirheumatic - Janus Kinase (Jak) Inhibitors': 'D-127',\n",
       "  'Antirheumatic Antimetabolites': 'D-128',\n",
       "  'Antiseborrheic Combinations': 'D-129',\n",
       "  'Antiseborrheic Products': 'D-130',\n",
       "  'Antiseptics - Mouth/Throat': 'D-131',\n",
       "  'Antispasmodics': 'D-132',\n",
       "  'Antithyroid Agents': 'D-133',\n",
       "  'Antitussive - Nonnarcotic': 'D-134',\n",
       "  'Antitussive - Opioid': 'D-135',\n",
       "  'Antitussive-Expectorant': 'D-136',\n",
       "  'Antitussive-Expectorants-Decongestant': 'D-137',\n",
       "  'Antiviral Monoclonal Antibodies': 'D-138',\n",
       "  'Antivirals - Topical': 'D-139',\n",
       "  'Applicators,Cotton Balls,etc': 'D-140',\n",
       "  'Aromatase Inhibitors': 'D-141',\n",
       "  'Artificial Tear Inserts': 'D-142',\n",
       "  'Artificial Tear and Lubricant Combinations': 'D-143',\n",
       "  'Astringents': 'D-144',\n",
       "  'Atopic Dermatitis - Monoclonal Antibodies': 'D-145',\n",
       "  'Azithromycin': 'D-146',\n",
       "  'B-Complex W/ C & Folic Acid': 'D-147',\n",
       "  'B-Complex W/ C-Zn & Folic Acid': 'D-148',\n",
       "  'Bacterial Vaccines': 'D-149',\n",
       "  'Barbiturate Hypnotics': 'D-150',\n",
       "  'Belladonna Alkaloids': 'D-151',\n",
       "  'Benzathiazoles': 'D-152',\n",
       "  'Benzisoxazoles': 'D-153',\n",
       "  'Benzodiazepine Hypnotics': 'D-154',\n",
       "  'Benzodiazepines': 'D-155',\n",
       "  'Beta Adrenergics': 'D-156',\n",
       "  'Beta Blocker & Diuretic Combinations': 'D-157',\n",
       "  'Beta Blockers Cardio-Selective': 'D-158',\n",
       "  'Beta Blockers Non-Selective': 'D-159',\n",
       "  'Beta-Blockers - Ophthalmic': 'D-160',\n",
       "  'Beta-Blockers - Ophthalmic Combinations': 'D-161',\n",
       "  'Bicarbonates': 'D-162',\n",
       "  'Biguanides': 'D-163',\n",
       "  'Bile Acid Sequestrants': 'D-164',\n",
       "  'Biphasic Contraceptives - Oral': 'D-165',\n",
       "  'Bisphosphonates': 'D-166',\n",
       "  'Bowel Evacuant Combinations': 'D-167',\n",
       "  'Bradykinin B2 Receptor Antagonists': 'D-168',\n",
       "  'Bronchodilators - Anticholinergics': 'D-169',\n",
       "  \"Bulk Chemicals - Ga's\": 'D-170',\n",
       "  \"Bulk Chemicals - Hy's\": 'D-171',\n",
       "  \"Bulk Chemicals - Me's\": 'D-172',\n",
       "  \"Bulk Chemicals - Ri's\": 'D-173',\n",
       "  'Bulk Chemicals - Ta': 'D-174',\n",
       "  'Burn Products': 'D-175',\n",
       "  'Butyrophenones': 'D-176',\n",
       "  'C1 Inhibitors': 'D-177',\n",
       "  'CXCR4 Receptor Antagonist': 'D-178',\n",
       "  'Calcimimetic Agents': 'D-179',\n",
       "  'Calcitonins': 'D-180',\n",
       "  'Calcium': 'D-181',\n",
       "  'Calcium Channel Blocker & Hmg CoA Reductase Inhibit Comb': 'D-182',\n",
       "  'Calcium Channel Blockers': 'D-183',\n",
       "  'Calcium Combinations': 'D-184',\n",
       "  'Carbamates': 'D-185',\n",
       "  'Carbapenems': 'D-186',\n",
       "  'Carbohydrates': 'D-187',\n",
       "  'Carbonic Anhydrase Inhibitors': 'D-188',\n",
       "  'Cardiac Glycosides': 'D-189',\n",
       "  'Carnitine Replenisher - Agents': 'D-190',\n",
       "  'Central Muscle Relaxants': 'D-191',\n",
       "  'Cephalosporins - 1st Generation': 'D-192',\n",
       "  'Cephalosporins - 2nd Generation': 'D-193',\n",
       "  'Cephalosporins - 3rd Generation': 'D-194',\n",
       "  'Cephalosporins - 4th Generation': 'D-195',\n",
       "  'Chelating Agents': 'D-196',\n",
       "  'Chemotherapy Adjuncts - Hyperuricemia Agents': 'D-197',\n",
       "  'Chlorine Antiseptics': 'D-198',\n",
       "  'Cholinomimetics - Ache Inhibitors': 'D-199',\n",
       "  'Cic Agents - Guanylate Cyclase-C (Gc-C) Agonists': 'D-200',\n",
       "  'Citrates': 'D-201',\n",
       "  'Clarithromycin': 'D-202',\n",
       "  'Cmv Agents': 'D-203',\n",
       "  'Cobalamins': 'D-204',\n",
       "  'Codeine Combinations': 'D-205',\n",
       "  'Combination Contraceptives - Oral': 'D-206',\n",
       "  'Combination Contraceptives - Transdermal': 'D-207',\n",
       "  'Combination Contraceptives - Vaginal': 'D-208',\n",
       "  'Condoms - Female': 'D-209',\n",
       "  'Continuous Contraceptives - Oral': 'D-210',\n",
       "  'Copper Contraceptives - Iud': 'D-211',\n",
       "  'Corticosteroids - Topical': 'D-212',\n",
       "  'Corticotropin': 'D-213',\n",
       "  'Coumarin Anticoagulants': 'D-214',\n",
       "  'Cyclin-Dependent Kinases (Cdk) Inhibitors': 'D-215',\n",
       "  'Cyclooxygenase 2 (COX-2) Inhibitors': 'D-216',\n",
       "  'Cycloplegic Mydriatics': 'D-217',\n",
       "  'Cyclosporine Analogs': 'D-218',\n",
       "  'Cystic Fibrosis Agent - Combinations': 'D-219',\n",
       "  'Cytotoxic Agents': 'D-220',\n",
       "  'DPP-4 Inhibitor-Thiazolidinedione Combinations': 'D-221',\n",
       "  'Decarboxylase Inhibitors': 'D-222',\n",
       "  'Decongestant & Antihistamine': 'D-223',\n",
       "  'Dental Products - Combinations': 'D-224',\n",
       "  'Depigmenting Agents': 'D-225',\n",
       "  'Depigmenting Combinations': 'D-226',\n",
       "  'Diabetic Other': 'D-227',\n",
       "  'Diagnostic Drugs': 'D-228',\n",
       "  'Diagnostic Tests': 'D-229',\n",
       "  'Diaphragms': 'D-230',\n",
       "  'Dibenzo-Oxepino Pyrroles': 'D-231',\n",
       "  'Dibenzodiazepines': 'D-232',\n",
       "  'Dibenzothiazepines': 'D-233',\n",
       "  'Dibenzoxazepines': 'D-234',\n",
       "  'Dietary Management Product Combinations': 'D-235',\n",
       "  'Dietary Management Products': 'D-236',\n",
       "  'Digestive Enzymes': 'D-237',\n",
       "  'Dipeptidyl Peptidase-4 (DPP-4) Inhibitors': 'D-238',\n",
       "  'Dipeptidyl Peptidase-4 Inhibitor-Biguanide Combinations': 'D-239',\n",
       "  'Direct Factor Xa Inhibitors': 'D-240',\n",
       "  'Direct Muscle Relaxants': 'D-241',\n",
       "  'Direct Renin Inhibitors': 'D-242',\n",
       "  'Direct Renin Inhibitors & Thiazide/Thiazide-Like Comb': 'D-243',\n",
       "  'Direct-Acting P2Y12 Inhibitors': 'D-244',\n",
       "  'Diuretic Combinations': 'D-245',\n",
       "  'Dopamine Receptor Agonists': 'D-246',\n",
       "  'Dopamine Receptor Agonists - Ergot Derivatives': 'D-247',\n",
       "  'Dry Mouth Agents and Artificial Saliva': 'D-248',\n",
       "  'Electrolytes & Dextrose': 'D-249',\n",
       "  'Emergency Contraceptives': 'D-250',\n",
       "  'Emollient/Keratolytic Agents': 'D-251',\n",
       "  'Emollient/Keratolytic Combinations': 'D-252',\n",
       "  'Emollients': 'D-253',\n",
       "  'Enzymes': 'D-254',\n",
       "  'Enzymes - Topical': 'D-255',\n",
       "  'Ergot Combinations': 'D-256',\n",
       "  'Erythromycins': 'D-257',\n",
       "  'Erythropoiesis-Stimulating Agents (ESAs)': 'D-258',\n",
       "  'Estrogen & Androgen': 'D-259',\n",
       "  'Estrogen & Progestin': 'D-260',\n",
       "  'Estrogen-Selective Estrogen Receptor Modulator Comb': 'D-261',\n",
       "  'Estrogens': 'D-262',\n",
       "  'Expectorants': 'D-263',\n",
       "  'Extended-Cycle Contraceptives - Oral': 'D-264',\n",
       "  'External Vehicle Ingredients': 'D-265',\n",
       "  'Eyelid Cleansers & Lubricants': 'D-266',\n",
       "  'Fabry Disease - Agents': 'D-267',\n",
       "  'Fibric Acid Derivatives': 'D-268',\n",
       "  'Fibromyalgia Agent - SNRIs': 'D-269',\n",
       "  'Fidaxomicin': 'D-270',\n",
       "  'Flavoring Agents': 'D-271',\n",
       "  'Fluoride': 'D-272',\n",
       "  'Fluoride Combinations': 'D-273',\n",
       "  'Fluoride Dental Products': 'D-274',\n",
       "  'Fluoroquinolones': 'D-275',\n",
       "  'Folic Acid Antagonists Rescue Agents': 'D-276',\n",
       "  'Folic Acid/Folate Combinations': 'D-277',\n",
       "  'Folic Acid/Folates': 'D-278',\n",
       "  'Four Phase Contraceptives - Oral': 'D-279',\n",
       "  'Gaba Modulators': 'D-280',\n",
       "  'Gallstone Solubilizing Agents': 'D-281',\n",
       "  'Gastrointestinal Antiallergy Agents': 'D-282',\n",
       "  'Gastrointestinal Chloride Channel Activators': 'D-283',\n",
       "  'Gastrointestinal Stimulants': 'D-284',\n",
       "  'Genitourinary Irrigants': 'D-285',\n",
       "  'Glucagon-Like Peptide-2 (GLP-2) Analogs': 'D-286',\n",
       "  'Glucocorticosteroids': 'D-287',\n",
       "  'Glucose Monitoring Test Supplies': 'D-288',\n",
       "  'GnRH/LHRH Antagonists': 'D-289',\n",
       "  'Gonadotropin Releasing Hormone (GnRH) Antagonists': 'D-290',\n",
       "  'Gout Agent Combinations': 'D-291',\n",
       "  'Gout Agents': 'D-292',\n",
       "  'Granulocyte Colony-Stimulating Factors (G-Csf)': 'D-293',\n",
       "  'Granulocyte/Macrophage Colony-Stimulating Factor(GM-CSF)': 'D-294',\n",
       "  'Growth Hormones': 'D-295',\n",
       "  'H-2 Antagonists': 'D-296',\n",
       "  'Hematorheologic Agents': 'D-297',\n",
       "  'Hemostatics - Systemic': 'D-298',\n",
       "  'Heparins and Heparinoid-Like Agents': 'D-299',\n",
       "  'Hepatitis B Agents': 'D-300',\n",
       "  'Hepatitis C Agent - Combinations': 'D-301',\n",
       "  'Hepatitis C Agents': 'D-302',\n",
       "  'Herpes Agents - Purine Analogues': 'D-303',\n",
       "  'Herpes Agents - Thymidine Analogues': 'D-304',\n",
       "  'Hmg CoA Reductase Inhibitors': 'D-305',\n",
       "  'Human Insulin': 'D-306',\n",
       "  'Hydantoins': 'D-307',\n",
       "  'Hydrocodone Combinations': 'D-308',\n",
       "  'Hydrolytic Enzymes': 'D-309',\n",
       "  'Hyperparathyroid Treatment - Vitamin D Analogs': 'D-310',\n",
       "  'Hypnotics - Tricyclic Agents': 'D-311',\n",
       "  'Ibs Agent - Guanylate Cyclase-C (Gc-C) Agonists': 'D-312',\n",
       "  'Ibs Agent - Mu-Opioid Receptor Agonists': 'D-313',\n",
       "  'Ibs Agent - Selective 5-HT3 Receptor Antagonists': 'D-314',\n",
       "  'Imidazole-Related Antifungals': 'D-315',\n",
       "  'Imidazole-Related Antifungals - Topical': 'D-316',\n",
       "  'Imidazoles': 'D-317',\n",
       "  'Imidazotetrazines': 'D-318',\n",
       "  'Immune Serums': 'D-319',\n",
       "  'Immunomodulators Imidazoquinolinamines - Topical': 'D-320',\n",
       "  'Immunomodulators for Myelodysplastic Syndromes': 'D-321',\n",
       "  'Incretin Mimetic Agents (GLP-1 Receptor Agonists)': 'D-322',\n",
       "  'Infant Foods': 'D-323',\n",
       "  'Inflammatory Bowel Agents': 'D-324',\n",
       "  'Influenza Agents': 'D-325',\n",
       "  'Inosine Monophosphate Dehydrogenase Inhibitors': 'D-326',\n",
       "  'Insulin Administration Supplies': 'D-327',\n",
       "  'Insulin-Incretin Mimetic Combinations': 'D-328',\n",
       "  'Integrin Receptor Antagonists': 'D-329',\n",
       "  'Interleukin Antagonists': 'D-330',\n",
       "  'Interleukin-1 Blockers': 'D-331',\n",
       "  'Interleukin-1beta Blockers': 'D-332',\n",
       "  'Interleukin-5 Antagonists (IgG1 Kappa)': 'D-333',\n",
       "  'Interleukin-6 Receptor Inhibitors': 'D-334',\n",
       "  'Interstitial Cystitis Agents': 'D-335',\n",
       "  'Intest Cholest Absorp Inhib-HMG CoA Reductase Inhib Comb': 'D-336',\n",
       "  'Intestinal Acidifiers': 'D-337',\n",
       "  'Intestinal Cholesterol Absorption Inhibitors': 'D-338',\n",
       "  'Intrarectal Steroids': 'D-339',\n",
       "  'Iodine Antiseptics': 'D-340',\n",
       "  'Iron': 'D-341',\n",
       "  'Iron Combinations': 'D-342',\n",
       "  'Iron W/ Vitamins': 'D-343',\n",
       "  'Iron-B12-Folate': 'D-344',\n",
       "  'Janus Associated Kinase (Jak) Inhibitors': 'D-345',\n",
       "  'Keratolytic/Antimitotic Agents': 'D-346',\n",
       "  'Laxatives - Miscellaneous': 'D-347',\n",
       "  'Leprostatics': 'D-348',\n",
       "  'Leukotriene Receptor Antagonists': 'D-349',\n",
       "  'Levodopa Combinations': 'D-350',\n",
       "  'Lhrh Analogs': 'D-351',\n",
       "  'Lincosamides': 'D-352',\n",
       "  'Lipase Inhibitors': 'D-353',\n",
       "  'Local Anesthetics - Amides': 'D-354',\n",
       "  'Local Anesthetics - Topical': 'D-355',\n",
       "  'Loop Diuretics': 'D-356',\n",
       "  'Low Molecular Weight Heparins': 'D-357',\n",
       "  'Lymphocyte Function-Associated Antigen-1 (LFA-1) Antag': 'D-358',\n",
       "  'Macrolide Immunosuppressants': 'D-359',\n",
       "  'Macrolide Immunosuppressants - Topical': 'D-360',\n",
       "  'Magnesium': 'D-361',\n",
       "  'Meglitinide Analogues': 'D-362',\n",
       "  'Migraine Products': 'D-363',\n",
       "  'Migraine Products - NSAIDs': 'D-364',\n",
       "  'Mineralocorticoids': 'D-365',\n",
       "  'Miotics - Direct Acting': 'D-366',\n",
       "  'Misc. Anti-Ulcer': 'D-367',\n",
       "  'Misc. Dermatological Products': 'D-368',\n",
       "  'Misc. Devices': 'D-369',\n",
       "  'Misc. Nutritional Substances': 'D-370',\n",
       "  'Misc. Respiratory Inhalants': 'D-371',\n",
       "  'Misc. Topical': 'D-372',\n",
       "  'Misc. Topical Combinations': 'D-373',\n",
       "  'Mitotic Inhibitors': 'D-374',\n",
       "  'Mixed Allergenic Extracts': 'D-375',\n",
       "  'Monoamine Oxidase Inhibitors (MAOIs)': 'D-376',\n",
       "  'Monobactams': 'D-377',\n",
       "  'Ms Agents - Pyrimidine Synthesis Inhibitors': 'D-378',\n",
       "  'Mucolytics': 'D-379',\n",
       "  'Multiple Sclerosis Agents': 'D-380',\n",
       "  'Multiple Sclerosis Agents - Interferons': 'D-381',\n",
       "  'Multiple Sclerosis Agents - Monoclonal Antibodies': 'D-382',\n",
       "  'Multiple Sclerosis Agents - Nrf2 Pathway Activators': 'D-383',\n",
       "  'Multiple Sclerosis Agents - Potassium Channel Blockers': 'D-384',\n",
       "  'Multiple Vitamins W/ Minerals': 'D-385',\n",
       "  'Multiple Vitamins W/ Minerals & Calcium-Folic Acid': 'D-386',\n",
       "  'Multiple Vitamins W/ Minerals & Folic Acid': 'D-387',\n",
       "  'Multivitamins': 'D-388',\n",
       "  'N-Methyl-D-Aspartate (Nmda) Receptor Antagonists': 'D-389',\n",
       "  'Nasal Agents - Misc.': 'D-390',\n",
       "  'Nasal Antibiotics': 'D-391',\n",
       "  'Nasal Anticholinergics': 'D-392',\n",
       "  'Nasal Antihistamines': 'D-393',\n",
       "  'Nasal Steroids': 'D-394',\n",
       "  'Natural Penicillins': 'D-395',\n",
       "  'Nebulizers': 'D-396',\n",
       "  'Needles & Syringes': 'D-397',\n",
       "  'Neprilysin Inhib (ARNI)-Angiotensin Ii Recept Antag Comb': 'D-398',\n",
       "  'Neuraminidase Inhibitors': 'D-399',\n",
       "  'Neuromuscular Blocking Agent - Neurotoxins': 'D-400',\n",
       "  'Niacinamide W/ Zinc-Copper & Folic Acid': 'D-401',\n",
       "  'Nicotinic Acid Derivatives': 'D-402',\n",
       "  'Nitrate & Vasodilator Combinations': 'D-403',\n",
       "  'Nitrate Vasodilating Agents': 'D-404',\n",
       "  'Nitrates': 'D-405',\n",
       "  'Nitrogen Mustards': 'D-406',\n",
       "  'Nitrosoureas': 'D-407',\n",
       "  'Non-Benzodiazepine - GABA-Receptor Modulators': 'D-408',\n",
       "  'Non-Narc Antitussive-Antihistamine': 'D-409',\n",
       "  'Non-Narc Antitussive-Decongestant-Antihistamine': 'D-410',\n",
       "  'Nonergoline Dopamine Receptor Agonists': 'D-411',\n",
       "  'Nonsteroidal Anti-Inflammatory Agent Combinations': 'D-412',\n",
       "  'Nonsteroidal Anti-Inflammatory Agents (NSAIDs)': 'D-413',\n",
       "  'Nutritional Supplements': 'D-414',\n",
       "  'Ophthalmic Anti-Infective Combinations': 'D-415',\n",
       "  'Ophthalmic Antiallergic': 'D-416',\n",
       "  'Ophthalmic Antibiotics': 'D-417',\n",
       "  'Ophthalmic Antivirals': 'D-418',\n",
       "  'Ophthalmic Carbonic Anhydrase Inhibitors': 'D-419',\n",
       "  'Ophthalmic Decongestants': 'D-420',\n",
       "  'Ophthalmic Immunomodulators': 'D-421',\n",
       "  'Ophthalmic Local Anesthetics': 'D-422',\n",
       "  'Ophthalmic Nonsteroidal Anti-Inflammatory Agents': 'D-423',\n",
       "  'Ophthalmic Selective Alpha Adrenergic Agonists': 'D-424',\n",
       "  'Ophthalmic Steroid Combinations': 'D-425',\n",
       "  'Ophthalmic Steroids': 'D-426',\n",
       "  'Ophthalmic Sulfonamides': 'D-427',\n",
       "  'Opioid Agonists': 'D-428',\n",
       "  'Opioid Antagonists': 'D-429',\n",
       "  'Opioid Antitussive-Antihistamine': 'D-430',\n",
       "  'Opioid Antitussive-Decongestant-Antihistamine': 'D-431',\n",
       "  'Opioid Combinations': 'D-432',\n",
       "  'Opioid Partial Agonists': 'D-433',\n",
       "  'Oral Vehicles': 'D-434',\n",
       "  'Orexin Receptor Antagonists': 'D-435',\n",
       "  'Ornithine Decarboxylase (Odc) Inhibitors - Topical': 'D-436',\n",
       "  'Otic Agents - Miscellaneous': 'D-437',\n",
       "  'Otic Analgesic Combinations': 'D-438',\n",
       "  'Otic Anti-Infectives': 'D-439',\n",
       "  'Otic Steroid-Anti-Infective Combinations': 'D-440',\n",
       "  'Otic Steroids': 'D-441',\n",
       "  'Ovulation Stimulants-Gonadotropins': 'D-442',\n",
       "  'Ovulation Stimulants-Synthetic': 'D-443',\n",
       "  'Oxaborole-Related Antifungals - Topical': 'D-444',\n",
       "  'Oxazolidinones': 'D-445',\n",
       "  'Oxytocics': 'D-446',\n",
       "  'PCSK9 Inhibitors': 'D-447',\n",
       "  'Parathyroid Hormone and Derivatives': 'D-448',\n",
       "  'Parenteral Vehicles': 'D-449',\n",
       "  'Ped Multi Vitamins W/Fl & Fe': 'D-450',\n",
       "  'Ped Mv W/ Fluoride': 'D-451',\n",
       "  'Ped Vitamins Acd Fluoride & Iron': 'D-452',\n",
       "  'Ped Vitamins Acd W/ Fluoride': 'D-453',\n",
       "  'Penicillin Combinations': 'D-454',\n",
       "  'Penicillinase-Resistant Penicillins': 'D-455',\n",
       "  'Periodontal Anti-Infectives': 'D-456',\n",
       "  'Peripheral Opioid Receptor Antagonists': 'D-457',\n",
       "  'Phenothiazines': 'D-458',\n",
       "  'Phenylketonuria Treatment - Agents': 'D-459',\n",
       "  'Phosphate': 'D-460',\n",
       "  'Phosphate Binder Agents': 'D-461',\n",
       "  'Phosphodiesterase 4 (PDE4) Inhibitors': 'D-462',\n",
       "  'Phosphodiesterase 4 (PDE4) Inhibitors - Topical': 'D-463',\n",
       "  'Phosphodiesterase Iii Inhibitors': 'D-464',\n",
       "  'Platelet Aggregation Inhibitor Combinations': 'D-465',\n",
       "  'Platelet Aggregation Inhibitors': 'D-466',\n",
       "  'Poly (ADP-ribose) Polymerase (Parp) Inhibitors': 'D-467',\n",
       "  'Postherpetic Neuralgia (PHN)/Neuropathic Pain Agents': 'D-468',\n",
       "  'Potassium': 'D-469',\n",
       "  'Potassium Removing Agents': 'D-470',\n",
       "  'Potassium Sparing Diuretics': 'D-471',\n",
       "  'Prenatal Mv & Min W/FE-FA': 'D-472',\n",
       "  'Prenatal Mv & Min W/FE-FA-CA-Omega 3 Fish Oil': 'D-473',\n",
       "  'Prenatal Mv & Min W/FE-FA-DHA': 'D-474',\n",
       "  'Progestin Contraceptives - Implants': 'D-475',\n",
       "  'Progestin Contraceptives - Injectable': 'D-476',\n",
       "  'Progestin Contraceptives - Iud': 'D-477',\n",
       "  'Progestin Contraceptives - Oral': 'D-478',\n",
       "  'Progestins': 'D-479',\n",
       "  'Progestins-Antineoplastic': 'D-480',\n",
       "  'Prostaglandin - Impotence Agents': 'D-481',\n",
       "  'Prostaglandin Vasodilators': 'D-482',\n",
       "  'Prostaglandins - Ophthalmic': 'D-483',\n",
       "  'Prostaglandins - Topical': 'D-484',\n",
       "  'Prostatic Hypertrophy Agent Combinations': 'D-485',\n",
       "  'Protease-Activated Receptor-1 (PAR-1) Antagonists': 'D-486',\n",
       "  'Protectants - Mouth/Throat': 'D-487',\n",
       "  'Proton Pump Inhibitor-Antacid Combinations': 'D-488',\n",
       "  'Proton Pump Inhibitors': 'D-489',\n",
       "  'Pseudobulbar Affect Agent Combinations': 'D-490',\n",
       "  'Psychotherapeutic and Neurological Agents - Misc.': 'D-491',\n",
       "  'Pulmonary Fibrosis Agents': 'D-492',\n",
       "  'Pulmonary Hypertension - Endothelin Receptor Antagonists': 'D-493',\n",
       "  'Pulmonary Hypertension - Phosphodiesterase Inhibitors': 'D-494',\n",
       "  'Pulmonary Hypertension - Prostacyclin Receptor Agonist': 'D-495',\n",
       "  'Purine Analogs': 'D-496',\n",
       "  'Pyrimidine Synthesis Inhibitors': 'D-497',\n",
       "  'Quaternary Anticholinergics': 'D-498',\n",
       "  'Quinazoline Agents': 'D-499',\n",
       "  'Quinolinone Derivatives': 'D-500',\n",
       "  'Rank Ligand (Rankl) Inhibitors': 'D-501',\n",
       "  'Rectal Anesthetic/Steroids': 'D-502',\n",
       "  'Rectal Steroids': 'D-503',\n",
       "  'Restless Leg Syndrome (Rls) Agents': 'D-504',\n",
       "  'Rosacea Agents': 'D-505',\n",
       "  'SGLT2 Inhibitor - DPP-4 Inhibitor Combinations': 'D-506',\n",
       "  'Salicylates': 'D-507',\n",
       "  'Saline Laxative Mixtures': 'D-508',\n",
       "  'Saliva Stimulants': 'D-509',\n",
       "  'Scabicides & Pediculicides': 'D-510',\n",
       "  'Scar Treatment Products': 'D-511',\n",
       "  'Selective Aldosterone Receptor Antagonists (SARAs)': 'D-512',\n",
       "  'Selective Costimulation Modulators': 'D-513',\n",
       "  'Selective Estrogen Receptor Modulators (SERMs)': 'D-514',\n",
       "  'Selective Melatonin Receptor Agonists': 'D-515',\n",
       "  'Selective Phosphodiesterase 4 (PDE4) Inhibitors': 'D-516',\n",
       "  'Selective Serotonin Agonist-NSAID Combinations': 'D-517',\n",
       "  'Selective Serotonin Agonists 5-HT(1)': 'D-518',\n",
       "  'Selective Serotonin Reuptake Inhibitors (SSRIs)': 'D-519',\n",
       "  'Selective cGMP Phosphodiesterase Type 5 Inhibitors': 'D-520',\n",
       "  'Semi Solid Vehicles': 'D-521',\n",
       "  'Serotonin 2C Receptor Agonists': 'D-522',\n",
       "  'Serotonin Modulators': 'D-523',\n",
       "  'Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)': 'D-524',\n",
       "  'Sinus Node Inhibitors': 'D-525',\n",
       "  'Skin Protectants': 'D-526',\n",
       "  'Smoking Deterrents': 'D-527',\n",
       "  'Sodium': 'D-528',\n",
       "  'Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors': 'D-529',\n",
       "  'Sodium-Glucose Co-Transporter 2 Inhibitor-Biguanide Comb': 'D-530',\n",
       "  'Soluble Tumor Necrosis Factor Receptor Agents': 'D-531',\n",
       "  'Solvents': 'D-532',\n",
       "  'Somatostatic Agents': 'D-533',\n",
       "  'Spacer/Aerosol-Holding Chambers & Supplies': 'D-534',\n",
       "  'Sphingosine 1-Phosphate (S1P) Receptor Modulators': 'D-535',\n",
       "  'Steroid Inhalants': 'D-536',\n",
       "  'Steroid-Local Anesthetic Combinations': 'D-537',\n",
       "  'Steroids - Mouth/Throat': 'D-538',\n",
       "  'Stimulants - Misc.': 'D-539',\n",
       "  'Substance P/Neurokinin 1 (NK1) Receptor Antagonists': 'D-540',\n",
       "  'Succinimides': 'D-541',\n",
       "  'Sulfonylurea-Biguanide Combinations': 'D-542',\n",
       "  'Sulfonylurea-Thiazolidinedione Combinations': 'D-543',\n",
       "  'Sulfonylureas': 'D-544',\n",
       "  'Synthetic Heparinoid-Like Agents': 'D-545',\n",
       "  'Systemic Decongestants': 'D-546',\n",
       "  'Tetracyclines': 'D-547',\n",
       "  'Thiazides and Thiazide-Like Diuretics': 'D-548',\n",
       "  'Thiazolidinedione-Biguanide Combinations': 'D-549',\n",
       "  'Thiazolidinediones': 'D-550',\n",
       "  'Thickening Agents': 'D-551',\n",
       "  'Thienbenzodiazepines': 'D-552',\n",
       "  'Thienbenzodiazepines & SSRIs': 'D-553',\n",
       "  'Thienopyridine Derivatives': 'D-554',\n",
       "  'Thioxanthenes': 'D-555',\n",
       "  'Thrombin Inhibitors - Selective Direct & Reversible': 'D-556',\n",
       "  'Thrombopoietin (Tpo) Receptor Agonists': 'D-557',\n",
       "  'Thyroid Hormones': 'D-558',\n",
       "  'Topical Anesthetic Combinations': 'D-559',\n",
       "  'Topical Steroid Combinations': 'D-560',\n",
       "  'Topoisomerase I Inhibitors': 'D-561',\n",
       "  'Toxoid Combinations': 'D-562',\n",
       "  'Tramadol Combinations': 'D-563',\n",
       "  'Triazoles': 'D-564',\n",
       "  'Tricyclic Agents': 'D-565',\n",
       "  'Triphasic Contraceptives - Oral': 'D-566',\n",
       "  'Tumor Necrosis Factor Alpha Blockers': 'D-567',\n",
       "  'Type Ii 5-Alpha Reductase Inhibitors': 'D-568',\n",
       "  'Ulcer Anti-Infective W/ Bismuth Combinations': 'D-569',\n",
       "  'Ulcer Anti-Infective W/ Proton Pump Inhibitors': 'D-570',\n",
       "  'Ulcer Drugs - Prostaglandins': 'D-571',\n",
       "  'Urea Cycle Disorder - Agents': 'D-572',\n",
       "  'Uricosurics': 'D-573',\n",
       "  'Urinary Analgesics': 'D-574',\n",
       "  'Urinary Anti-Infectives': 'D-575',\n",
       "  'Urinary Antiseptic-Antispasmodic &/Or Analgesics': 'D-576',\n",
       "  'Urinary Antispasmodic - Antimuscarinic (Anticholinergic)': 'D-577',\n",
       "  'Urinary Antispasmodics - Beta-3 Adrenergic Agonists': 'D-578',\n",
       "  'Urinary Antispasmodics - Cholinergic Agonists': 'D-579',\n",
       "  'Urinary Antispasmodics - Direct Muscle Relaxants': 'D-580',\n",
       "  'Urinary Tract Protective Agents': 'D-581',\n",
       "  'Vaginal Anti-Infectives': 'D-582',\n",
       "  'Vaginal Estrogens': 'D-583',\n",
       "  'Vaginal Progestins': 'D-584',\n",
       "  'Valproic Acid': 'D-585',\n",
       "  'Vascular Endothelial Growth Factor (Vegf) Antagonists': 'D-586',\n",
       "  'Vascular Endothelial Growth Factor (Vegf) Inhibitors': 'D-587',\n",
       "  'Vasodilators': 'D-588',\n",
       "  'Vasomotor Symptom Agents - SSRIs': 'D-589',\n",
       "  'Vasopressin': 'D-590',\n",
       "  'Vasopressors': 'D-591',\n",
       "  'Viral Vaccine Combinations': 'D-592',\n",
       "  'Viral Vaccines': 'D-593',\n",
       "  'Viscosupplements': 'D-594',\n",
       "  'Vitamin B-1': 'D-595',\n",
       "  'Vitamin B-6': 'D-596',\n",
       "  'Vitamin C': 'D-597',\n",
       "  'Vitamin D': 'D-598',\n",
       "  'Vitamin K': 'D-599',\n",
       "  'Wound Care - Growth Factor Agents': 'D-600',\n",
       "  'Wound Care Combinations': 'D-601',\n",
       "  'Wound Dressings': 'D-602',\n",
       "  'Xanthines': 'D-603'})"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from data_pipeline import analyze_treatment \n",
    "analyze_treatment()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2b\"></a>\n",
    "### Encoding prescriptions\n",
    "- Each `drug_class` is encoded with a prefix 'D' (by default), following by '-' and an index ranging from 0 to 603 (since there are 604 drug classes in total) i.e. D-0, D-1, ... , D-603"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from utils import demo_encode_treatment\n",
    "demo_encode_treatment()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2c\"></a>\n",
    "### Sequencing prescriptions \n",
    "- Generating *p-sequences* helps us identify important prescriptions\n",
    "- Use TF-IDF to idenify important prescriptions for each patients\n",
    "\n",
    "- Once we know the most import prescriptions (say top 10) for each patient, we can then take the union of top prescriptions across patients to arrive at the final set of prescriptions, which is likely smaller than the total number of prescriptions. This could help reduce the number of variables when predicting health status.\n",
    "    - We'll skip this step for the purpose of this demo by using all prescriptions as variables.\n",
    "\n",
    "#### Observations\n",
    "- From the sequencing process, we find that prescription drugs can be duplicated in the same session; this is unlike the case of ICD10, for which we'd expect no duplicates in the same session"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# this takes some time!\n",
    "\n",
    "from utils import demo_sequencing\n",
    "demo_sequencing(dtype='treat', verbose=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2d\"></a>\n",
    "### Find the most important drug prescriptions\n",
    "- Given the p-sequences, we can then conveniently use them as inputs to the TF-IDF model to find the most important prescriptions for each patient. \n",
    "- Note that the sequenced representation is helpful as a format for training seq2seq model (i.e. using prescription sequences to predict likely diagnosis segments); however, we will not use this approach in this demo/prototype"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Treatment] Loading sequenced treatment/prescriptions file from:\n",
      "/Users/pleiades/Documents/work/interview/Merck/Prescriptions-sequenced.csv\n",
      "\n",
      "(eval_topn_features) Nd: 82546, dim(Xtr): (82546, 568), size(vocab): 568\n",
      "... example feature names (n=568=?=568):\n",
      "['D-0', 'D-1', 'D-10', 'D-100', 'D-101', 'D-102', 'D-103', 'D-104', 'D-105', 'D-106', 'D-107', 'D-108', 'D-109', 'D-11', 'D-110', 'D-111', 'D-112', 'D-113', 'D-114', 'D-115', 'D-116', 'D-117', 'D-118', 'D-119', 'D-12', 'D-120', 'D-121', 'D-122', 'D-123', 'D-124', 'D-126', 'D-127', 'D-128', 'D-129', 'D-13', 'D-130', 'D-131', 'D-132', 'D-133', 'D-134', 'D-135', 'D-136', 'D-138', 'D-139', 'D-14', 'D-140', 'D-141', 'D-142', 'D-144', 'D-145']\n",
      "['D-596', 'D-597', 'D-598', 'D-599', 'D-6', 'D-60', 'D-600', 'D-601', 'D-602', 'D-603', 'D-61', 'D-62', 'D-63', 'D-64', 'D-65', 'D-66', 'D-67', 'D-68', 'D-69', 'D-7', 'D-70', 'D-71', 'D-74', 'D-75', 'D-76', 'D-77', 'D-78', 'D-79', 'D-8', 'D-80', 'D-81', 'D-82', 'D-83', 'D-84', 'D-85', 'D-86', 'D-87', 'D-88', 'D-89', 'D-9', 'D-90', 'D-91', 'D-92', 'D-93', 'D-94', 'D-95', 'D-96', 'D-97', 'D-98', 'D-99']\n",
      "\n",
      "--- doc #2043 ---\n",
      "  feature  score\n",
      "0   D-479    1.0\n",
      "...... top N(5) features: D-479\n",
      "\n",
      "--- doc #20867 ---\n",
      "  feature     score\n",
      "0   D-564  0.861767\n",
      "1   D-582  0.383781\n",
      "2   D-454  0.244778\n",
      "3   D-593  0.223949\n",
      "...... top N(5) features: D-564 D-582 D-454 D-593\n",
      "\n",
      "--- doc #28749 ---\n",
      "  feature     score\n",
      "0    D-25  0.800866\n",
      "1   D-194  0.598844\n",
      "...... top N(5) features: D-25 D-194\n",
      "\n",
      "--- doc #31410 ---\n",
      "  feature  score\n",
      "0    D-25    1.0\n",
      "...... top N(5) features: D-25\n",
      "\n",
      "--- doc #34270 ---\n",
      "  feature     score\n",
      "0   D-288  0.733510\n",
      "1     D-4  0.489277\n",
      "2   D-229  0.347129\n",
      "3   D-163  0.251173\n",
      "4   D-305  0.197445\n",
      "...... top N(5) features: D-288 D-4 D-229 D-163 D-305\n",
      "\n",
      "--- doc #44037 ---\n",
      "  feature     score\n",
      "0    D-27  0.993926\n",
      "1   D-191  0.110053\n",
      "...... top N(5) features: D-27 D-191\n",
      "\n",
      "--- doc #46481 ---\n",
      "  feature     score\n",
      "0   D-544  0.779701\n",
      "1   D-305  0.468223\n",
      "2   D-163  0.297816\n",
      "3     D-4  0.290069\n",
      "...... top N(5) features: D-544 D-305 D-163 D-4\n",
      "\n",
      "--- doc #60848 ---\n",
      "  feature     score\n",
      "0   D-131  0.793001\n",
      "1   D-275  0.609220\n",
      "...... top N(5) features: D-131 D-275\n",
      "\n",
      "--- doc #66197 ---\n",
      "  feature  score\n",
      "0   D-593    1.0\n",
      "...... top N(5) features: D-593\n",
      "\n",
      "--- doc #73824 ---\n",
      "  feature  score\n",
      "0   D-454    1.0\n",
      "...... top N(5) features: D-454\n",
      "\n",
      "(eval_topn_features) top N features overall across all docs ...\n",
      "... doc(mean):\n",
      "  feature     score\n",
      "0   D-519  0.048906\n",
      "1   D-305  0.047891\n",
      "2   D-206  0.046719\n",
      "3   D-413  0.042440\n",
      "4    D-25  0.042405\n",
      "5   D-593  0.040971\n",
      "6   D-146  0.039003\n",
      "7   D-558  0.037068\n",
      "8   D-287  0.032760\n",
      "9     D-4  0.027681\n",
      "\n",
      "> Most common primary prescritpions: D-305(Hmg CoA Reductase Inhibitors), n=7927\n",
      "> Least common primary prescritpions: D-576(Urinary Antiseptic-Antispasmodic &/Or Analgesics), n=1\n",
      "> There are n=560 prescritpion codes in total.\n"
     ]
    }
   ],
   "source": [
    "from utils import demo_topn_prescriptions\n",
    "demo_topn_prescriptions()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2e\"></a>\n",
    "### Using prescriptions to predict health status\n",
    "Earlier we used the __top-n primary diagnoses (subject to the contraint of recency) to characterize a patient's health status__. In the demo, we set n=3 and n_days_lookback=180 (as a reminder, this means that we only consider the d-sequences at most 180 days long counting from the most recent visit). \n",
    "  - Certainly, the *n* in top-n, *window size*, *n_days_lookback* are all considered as adjustable hyperparameters to be optimized \n",
    "- For simplicity and as a baseline method, we could formulate the health-status predictive problem by predicting a single diagnosis code one at a time. \n",
    "  - In this manner, we will then build a model for each of the primary diagnosis associated with a patient's health status \n",
    "  - However, there are n=10678 models to train (see the following cell), some of which may not even have sufficient sample sizes for a regular statistical model\n",
    "  - Training a large set of models is usually not an issue, which can be put in a loop and trained off-line. But for the purpose of this demo, I'll only focus on 10 ICD10 codes selected from the most popular primary diagnoses to see if  any skills that can be learned from the data using prescriptions.\n",
    "  \n",
    "- I'll briefly discuss alternative formulations shortly\n",
    "  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Diagnosis] Loading sequenced diagnosis file from:\n",
      "/Users/pleiades/Documents/work/interview/Merck/Diagnosis-sequenced.csv\n",
      "\n",
      "> Found n=10678 unique primary diagnosis codes.\n"
     ]
    }
   ],
   "source": [
    "from utils import Diagnosis\n",
    "import collections\n",
    "\n",
    "dp = Diagnosis.properties\n",
    "col_key = dp['id']\n",
    "col_history = dp['history']\n",
    "col_status = dp['status']\n",
    "\n",
    "df_seq = Diagnosis.load(dtype='seq', verbose=True)\n",
    "counter = collections.Counter()\n",
    "for status in df_seq[col_status].values: \n",
    "    counter.update(status.split())\n",
    "print(f\"> Found n={len(counter)} unique primary diagnosis codes.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2f\"></a>\n",
    "### Model formulation\n",
    "\n",
    "- Explanatory variables (or features): All the distinctive prescription drugs will be used as candidate explanatory variables (alternatively you could use top-n prescriptions as a screening mechanism to reduce the variable set; see module `utils`, in particular method `eval_topn_prescriptions()` of the `Treatment` class)\n",
    "   - For convenience, prescription drugs are coded according to `drug_class` (D-1 ~ D-603)\n",
    "   - Number of variables: 604\n",
    "- Response variable (or label): In principle, all the primary diagnosis codes are potential targets; however, I'll demonstrate 10 target ICD10 codes for this demo\n",
    "   - Training the model for the remaining ICD10 codes is a similar process; however, there are codes with very low sample sizes, for which we will then have to resort to either data augmentation or rule-based approach \n",
    "   - From the data augmentation perspective, we could consider training **similar ICD10 codes** aggregately as a single model (e.g. all codes with the same first 3 digits); in the interest of time, I'll not address this in this demo\n",
    "   - The notion of the **temporal alignment** mentioned earlier can be thought of as a rule-based approach. It's much more likely for any prescription drugs with dates close to the diagnosis date to be relevant and predictive; therefore, when the sample size is too low, this alignment rule is a good heurstic."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Matching prescriptions with a given diagnosis date\n",
    "- The ideal values for W is a hyperparameter to be optimized or can be given by domain experts\n",
    "- The `match` operation is defined in module `utils`, which identifies all the prescription drugs that fall within the scope of a given W associated with a diagnosis date"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(match) Total number of patients: 66608\n",
      "(match) Number of patients with diagnosis J06.9: 5700\n",
      "(match) Number of patients who had been given prescriptions for diagnosis J06.9: 5700\n",
      "... n(diagnosed): 5700 >=? n(treated): 5700\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/pleiades/Documents/work/interview/Merck/utils.py:335: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df[col] = s.apply(lambda x: x[i])\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(match) diagnosis table with the window of dates determined (W=(60, 60)):\n",
      "Index(['Patient_id', 'Diag_date', 'ICD10', 'Diag_min', 'Diag_max'], dtype='object')\n",
      "\n",
      "... sampled dataframe:\n",
      "+--------------+-------------+---------+------------+------------+\n",
      "| Patient_id   | Diag_date   | ICD10   | Diag_min   | Diag_max   |\n",
      "|--------------+-------------+---------+------------+------------|\n",
      "| P00014       | 2018-04-19  | J06.9   | 2018-02-18 | 2018-05-24 |\n",
      "| P00037       | 2018-01-31  | J06.9   | 2017-12-02 | 2018-04-01 |\n",
      "| P00054       | 2017-01-05  | J06.9   | 2016-11-06 | 2017-03-06 |\n",
      "| P00054       | 2017-11-05  | J06.9   | 2017-09-06 | 2018-01-04 |\n",
      "| P00056       | 2017-01-15  | J06.9   | 2016-11-16 | 2017-03-16 |\n",
      "| P00075       | 2017-02-01  | J06.9   | 2016-12-03 | 2017-04-02 |\n",
      "| P00075       | 2018-01-20  | J06.9   | 2017-11-21 | 2018-03-21 |\n",
      "| P00096       | 2017-12-17  | J06.9   | 2017-10-18 | 2018-02-15 |\n",
      "| P00109       | 2017-10-26  | J06.9   | 2017-08-27 | 2017-12-25 |\n",
      "| P00117       | 2016-12-26  | J06.9   | 2016-10-27 | 2017-02-24 |\n",
      "+--------------+-------------+---------+------------+------------+\n",
      "\n",
      "(match) Found n=5194 patients with matching prescription records\n"
     ]
    }
   ],
   "source": [
    "from utils import demo_match\n",
    "\n",
    "target_codes = ['J06.9', ]\n",
    "W = (60, 60)\n",
    "demo_match(target_codes, W, verbose=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2g\"></a>\n",
    "### Creating Training examples\n",
    "- The making of training examples is a direct application of `match()` in module `utils`\n",
    "- Creating positive examples for a given diagnosis (say J06.9) is straightforward; each patient constitutes a training example. Recall that we've set `n_days_lookback` = 180, which results in *d-sequences* to be at most 180 days long and within this time frame, we'll then loop through all the diagnosis dates, each of which is associated with a set of relevant prescriptions, qualified via W and the given diagnosis date (d). Note that it's possible that no prescriptions can be found at all given W and d.\n",
    "- Creating negative examples is trickier and is perhaps an open question. What is the most reasonable control group for J06.9 (acute upper respiratory infection)? In principle, any diagnosis code that is not J06.9 can serve as negative examples because after all we are trying to predict 'yes' or 'no' for candidate cases of J06.9. **However**, ...\n",
    "  - The set of all possible negative examples is too huge and not all of them are meaningful as part of a control group\n",
    "  - If we include samples whose treatment pathways or prescription histories are too \"different\" than our target patients of J06.9, then very likely we will be getting a very trial model \n",
    "  - We may want to incorporate substantial amounts of \"similar patients\" of varing degrees so that the resulting decision boundary is robust enough to distinguish nuances of minor prescription differences\n",
    "  - As a trade-off, I'll include __a mixture of both similar and different cases, as negatives, in terms of the ICD hierarchy__. For instance, when predicting positive cases of J06.9, the classifier should learn to distinguish it from codes that **look like J06 (caveat?) but not J06.9 itself** -- as well as J0x and Jxx, i.e. the set of negative examples contain those cases associated with diagnoses of potentially very similar categories. \n",
    "    - I put a question mark in the first scenario because perhaps that's too \"harsh\" for the classifier. An alternative way (perhaps a better way) is to exclude all J06 (regardless of its subcategories) because the distinction in subcategories is likely too subtle for prescriptions (a proxy for pharmacists and clinicians) to tell them apart.\n",
    "    - Any codes that do not fall into the J00-J99 category are considered as substatially different (than our target J06.9), which are proportionally mixed into the control group as well.\n",
    "- For the purpose of the demo, I did not intend to optimze the control group."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from utils import demo_make_classification\n",
    "\n",
    "target_codes = ['J06.9', ] # ['I10', 'N39.0', 'E78.2', 'F41.9', 'K21.9', 'J20.9', 'M54.5', 'L70.0', 'J06.9', 'E11.9']\n",
    "demo_make_classification(target_codes=target_codes, W=(60, 60))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2h\"></a>\n",
    "### Model training and evaluating \n",
    "\n",
    "- We'll use logistic regression with *l1* regularization (i.e. lasso) in this demo; any model class that deals with sparsity works relatively well in this case becasue a patient had likely only used a few drugs, a small ratio compared to the entire set of candidate drugs (see the output of `demo_make_classification()` for more details on this).\n",
    "- In this demo, model selection is not addressed E.g. choosing optimial regularization strength, optimal W -- and technically also including length of the d-sequence (recency), and importance weighting schemes on diagnosis and prescriptions, among others.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/utils/validation.py:760: DataConversionWarning: A column-vector y was passed when a 1d array was expected. Please change the shape of y to (n_samples, ), for example using ravel().\n",
      "  y = column_or_1d(y, warn=True)\n",
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/linear_model/_sag.py:330: ConvergenceWarning: The max_iter was reached which means the coef_ did not converge\n",
      "  \"the coef_ did not converge\", ConvergenceWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(saveFig) Saving plot to:\n",
      "plot/J069-precision_recall_curve.tif\n",
      "... description: [output] precision recall curve\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/utils/validation.py:760: DataConversionWarning: A column-vector y was passed when a 1d array was expected. Please change the shape of y to (n_samples, ), for example using ravel().\n",
      "  y = column_or_1d(y, warn=True)\n",
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/linear_model/_sag.py:330: ConvergenceWarning: The max_iter was reached which means the coef_ did not converge\n",
      "  \"the coef_ did not converge\", ConvergenceWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(saveFig) Saving plot to:\n",
      "plot/J069-precision_recall_curve-1.tif\n",
      "... description: [output] precision recall curve\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/utils/validation.py:760: DataConversionWarning: A column-vector y was passed when a 1d array was expected. Please change the shape of y to (n_samples, ), for example using ravel().\n",
      "  y = column_or_1d(y, warn=True)\n",
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/linear_model/_sag.py:330: ConvergenceWarning: The max_iter was reached which means the coef_ did not converge\n",
      "  \"the coef_ did not converge\", ConvergenceWarning)\n",
      "/Users/pleiades/Documents/work/interview/Merck/evaluate.py:272: RuntimeWarning: invalid value encountered in true_divide\n",
      "  f1 = (1 + beta**2) * (precision * recall) / ((beta**2 * precision) + recall)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(saveFig) Saving plot to:\n",
      "plot/J069-precision_recall_curve-2.tif\n",
      "... description: [output] precision recall curve\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/utils/validation.py:760: DataConversionWarning: A column-vector y was passed when a 1d array was expected. Please change the shape of y to (n_samples, ), for example using ravel().\n",
      "  y = column_or_1d(y, warn=True)\n",
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/linear_model/_sag.py:330: ConvergenceWarning: The max_iter was reached which means the coef_ did not converge\n",
      "  \"the coef_ did not converge\", ConvergenceWarning)\n",
      "/Users/pleiades/Documents/work/interview/Merck/evaluate.py:272: RuntimeWarning: invalid value encountered in true_divide\n",
      "  f1 = (1 + beta**2) * (precision * recall) / ((beta**2 * precision) + recall)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(saveFig) Saving plot to:\n",
      "plot/J069-precision_recall_curve-3.tif\n",
      "... description: [output] precision recall curve\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/utils/validation.py:760: DataConversionWarning: A column-vector y was passed when a 1d array was expected. Please change the shape of y to (n_samples, ), for example using ravel().\n",
      "  y = column_or_1d(y, warn=True)\n",
      "/Users/pleiades/anaconda3/lib/python3.7/site-packages/sklearn/linear_model/_sag.py:330: ConvergenceWarning: The max_iter was reached which means the coef_ did not converge\n",
      "  \"the coef_ did not converge\", ConvergenceWarning)\n",
      "/Users/pleiades/Documents/work/interview/Merck/evaluate.py:272: RuntimeWarning: invalid value encountered in true_divide\n",
      "  f1 = (1 + beta**2) * (precision * recall) / ((beta**2 * precision) + recall)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(saveFig) Saving plot to:\n",
      "plot/J069-precision_recall_curve-4.tif\n",
      "... description: [output] precision recall curve\n",
      "[plot] Saving ROC curve to:\n",
      "plot/J069-roc\n",
      "\n",
      "(saveFig) Saving plot to:\n",
      "plot/J069-roc.tif\n",
      "... description: [output] ROC curve\n",
      "[demo] Fmax average: 0.5110610954207966, std: 0.004718485682787911\n",
      "[demo] Fold #[0]: \n",
      "       [scores] -> {'AUROC': 0.6436711685783993, 'AUPRC': 0.4172272299902758, 'precision': 0.3932878867330886, 'recall': 0.7218479307025987, 'accuracy': 0.5602189781021898}\n",
      "[demo] Fold #[1]: \n",
      "       [scores] -> {'AUROC': 0.641216436264476, 'AUPRC': 0.42078682514720683, 'precision': 0.38788192646297254, 'recall': 0.7208854667949952, 'accuracy': 0.5523114355231143}\n",
      "[demo] Fold #[2]: \n",
      "       [scores] -> {'AUROC': 0.6351337413997709, 'AUPRC': 0.4111617466023717, 'precision': 0.38173652694610777, 'recall': 0.7362848893166506, 'accuracy': 0.5398418491484185}\n",
      "[demo] Fold #[3]: \n",
      "       [scores] -> {'AUROC': 0.6236365986208822, 'AUPRC': 0.4077816707692208, 'precision': 0.3734015345268542, 'recall': 0.7025986525505293, 'accuracy': 0.5334549878345499}\n",
      "[demo] Fold #[4]: \n",
      "       [scores] -> {'AUROC': 0.6364512952258617, 'AUPRC': 0.41054502453810987, 'precision': 0.38205645161290325, 'recall': 0.7302504816955684, 'accuracy': 0.541970802919708}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/pleiades/Documents/work/interview/Merck/plot_utils.py:127: UserWarning: Matplotlib is currently using agg, which is a non-GUI backend, so cannot show the figure.\n",
      "  plt.show()\n"
     ]
    }
   ],
   "source": [
    "from sklearn.linear_model import LogisticRegression\n",
    "from evaluate import demo_evaluate_health_status_prediction\n",
    "\n",
    "classifier =  LogisticRegression(class_weight='balanced', penalty='l1', solver='saga')\n",
    "target_codes = ['J06.9', ] # ['I10', 'N39.0', 'E78.2', 'F41.9', 'K21.9', 'J20.9', 'M54.5', 'L70.0',, 'E11.9']\n",
    "n_folds = 5 # 5-fold cross validation\n",
    "\n",
    "demo_evaluate_health_status_prediction(target_codes=target_codes, model=classifier, show_plot=True, n_folds=n_folds)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a name=\"q2i\"></a>\n",
    "### Other potential methods\n",
    "- As a multilabel classification problem\n",
    "   - We've used multiple (primary) diagnoses to characterize a patient's health status \n",
    "   - It's possible that these primary diagnoses are correlated and therefore better to be characterized as a multilabel prediction problem. This is in contrary to what we've done so far, where we've treated each primary diagnosis as independent\n",
    "- As a seq2seq classification problem\n",
    "  - Prescriptions and their ordings are captured by p-sequences; similarly, primary diagnoses (as health status) can be ordered according to the diagnosis sequence as well\n",
    "  - Note that the temporal ordering is operated on the level of sessions (or dates). Prescriptions and ICD10 codes within the same session (date) are usually not ordered. \n",
    "- As a collaborative filtering problem \n",
    "  - We could potentially treat prescriptions as \"items\" and diagnoses as \"users\" or any two entities that make sense. \n",
    "  - A prescription is a match to a diagnosis if it's indeed used to treat that diagnosis or they tend to co-occur. \n",
    "  - Similarly a prescription is not a match to a diagnosis, if they tend not to be related clinically \n",
    "  - We can then form a \"rating\" matrix using prescriptions as rows and diagnoses as columns and the cells in the matrix represents \"implicit feedback\" (i.e. 1 represents preferred/matched whereas 0 represents not preferred/not matched)\n",
    "  - This can be solved by matrix factorization-related methods using alternate least square for example. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
